UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT
OF
REGISTERED MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number: 811-03916
Name of Registrant: | Vanguard Specialized Funds |
Address of Registrant: | P.O. Box 2600 |
Valley Forge, PA 19482 |
Name and address of agent for service: | John E. Schadl, Esquire |
P.O. Box 876 | |
Valley Forge, PA 19482 |
Registrant’s telephone number, including area code: (610) 669-1000
Date of fiscal year end: January 31
Date of reporting period: February 1, 2024—July 31, 2024
Item 1: Reports to Shareholders.
This semi-annual shareholder report contains important information about Vanguard Energy Fund (the "Fund") for the period of February 1, 2024, to July 31, 2024. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Share Class Name | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
---|---|---|
Investor Shares | $24 | 0.44%Footnote Reference1 |
Footnote | Description |
Footnote1 | Annualized. |
This table reflects the Fund's investments, including short-term investments and other assets and liabilities.
Portfolio Composition % of Net Assets
(as of July 31, 2024)
North America | 63.3% |
Europe | 32.5% |
Asia | 2.7% |
South America | 1.1% |
Other Assets and Liabilities—Net | 0.4% |
Fund Statistics
(as of July 31, 2024)
Fund Net Assets (in millions) | $5,896 |
Number of Portfolio Holdings | 47 |
Portfolio Turnover Rate | 19% |
Where can I find additional information about the Fund?
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2024 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR51
This semi-annual shareholder report contains important information about Vanguard Energy Fund (the "Fund") for the period of February 1, 2024, to July 31, 2024. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Share Class Name | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
---|---|---|
Admiral Shares | $19 | 0.36%Footnote Reference1 |
Footnote | Description |
Footnote1 | Annualized. |
This table reflects the Fund's investments, including short-term investments and other assets and liabilities.
Portfolio Composition % of Net Assets
(as of July 31, 2024)
North America | 63.3% |
Europe | 32.5% |
Asia | 2.7% |
South America | 1.1% |
Other Assets and Liabilities—Net | 0.4% |
Fund Statistics
(as of July 31, 2024)
Fund Net Assets (in millions) | $5,896 |
Number of Portfolio Holdings | 47 |
Portfolio Turnover Rate | 19% |
Where can I find additional information about the Fund?
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2024 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR551
This semi-annual shareholder report contains important information about Vanguard Health Care Fund (the "Fund") for the period of February 1, 2024, to July 31, 2024. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Share Class Name | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
---|---|---|
Investor Shares | $20 | 0.38%Footnote Reference1 |
Footnote | Description |
Footnote1 | Annualized. |
This table reflects the Fund's investments, including short-term investments and other assets and liabilities.
Portfolio Composition % of Net Assets
(as of July 31, 2024)
North America | 67.8% |
Europe | 21.4% |
Asia | 8.7% |
South America | 0.0% |
Other Assets and Liabilities—Net | 2.1% |
Fund Statistics
(as of July 31, 2024)
Fund Net Assets (in millions) | $48,824 |
Number of Portfolio Holdings | 107 |
Portfolio Turnover Rate | 15% |
Where can I find additional information about the Fund?
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2024 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR52
This semi-annual shareholder report contains important information about Vanguard Health Care Fund (the "Fund") for the period of February 1, 2024, to July 31, 2024. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Share Class Name | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
---|---|---|
Admiral Shares | $17 | 0.33%Footnote Reference1 |
Footnote | Description |
Footnote1 | Annualized. |
This table reflects the Fund's investments, including short-term investments and other assets and liabilities.
Portfolio Composition % of Net Assets
(as of July 31, 2024)
North America | 67.8% |
Europe | 21.4% |
Asia | 8.7% |
South America | 0.0% |
Other Assets and Liabilities—Net | 2.1% |
Fund Statistics
(as of July 31, 2024)
Fund Net Assets (in millions) | $48,824 |
Number of Portfolio Holdings | 107 |
Portfolio Turnover Rate | 15% |
Where can I find additional information about the Fund?
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2024 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR552
This semi-annual shareholder report contains important information about Vanguard Dividend Growth Fund (the "Fund") for the period of February 1, 2024, to July 31, 2024. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Share Class Name | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
---|---|---|
Investor Shares | $12 | 0.23%Footnote Reference1 |
Footnote | Description |
Footnote1 | Annualized. |
This table reflects the Fund's investments, including short-term investments and other assets and liabilities.
Portfolio Composition % of Net Assets
(as of July 31, 2024)
Consumer Discretionary | 9.8% | |
Consumer Staples | 12.8% | |
Financials | 14.8% | |
Health Care | 19.1% | |
Industrials | 18.5% | |
Information Technology | 15.2% | |
Materials | 5.0% | |
Real Estate | 3.1% | |
Other Assets and Liabilities—Net | 1.7% |
Fund Statistics
(as of July 31, 2024)
Fund Net Assets (in millions) | $52,865 |
Number of Portfolio Holdings | 49 |
Portfolio Turnover Rate | 7% |
Where can I find additional information about the Fund?
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2024 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR57
Vanguard Dividend Appreciation Index Fund
ETF Shares (VIG) NYSE Arca
Semi-Annual Shareholder Report | July 31, 2024
This semi-annual shareholder report contains important information about Vanguard Dividend Appreciation Index Fund (the "Fund") for the period of February 1, 2024, to July 31, 2024. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Share Class Name | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
---|---|---|
ETF Shares | $3 | 0.06%Footnote Reference1 |
Footnote | Description |
Footnote1 | Annualized. |
This table reflects the Fund's investments, including short-term investments, derivatives and other assets and liabilities.
Portfolio Composition % of Net Assets
(as of July 31, 2024)
Communication Services | 0.9% | |
Consumer Discretionary | 6.0% | |
Consumer Staples | 11.4% | |
Energy | 3.4% | |
Financials | 20.2% | |
Health Care | 15.9% | |
Industrials | 12.1% | |
Information Technology | 23.5% | |
Materials | 4.0% | |
Utilities | 2.3% | |
Other Assets and Liabilities—Net | 0.3% |
Fund Statistics
(as of July 31, 2024)
Fund Net Assets (in millions) | $97,344 |
Number of Portfolio Holdings | 344 |
Portfolio Turnover Rate | 10% |
Where can I find additional information about the Fund?
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2024 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR920
Vanguard Dividend Appreciation Index Fund
Admiral™ Shares (VDADX)
Semi-Annual Shareholder Report | July 31, 2024
This semi-annual shareholder report contains important information about Vanguard Dividend Appreciation Index Fund (the "Fund") for the period of February 1, 2024, to July 31, 2024. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Share Class Name | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
---|---|---|
Admiral Shares | $4 | 0.08%Footnote Reference1 |
Footnote | Description |
Footnote1 | Annualized. |
This table reflects the Fund's investments, including short-term investments, derivatives and other assets and liabilities.
Portfolio Composition % of Net Assets
(as of July 31, 2024)
Communication Services | 0.9% | |
Consumer Discretionary | 6.0% | |
Consumer Staples | 11.4% | |
Energy | 3.4% | |
Financials | 20.2% | |
Health Care | 15.9% | |
Industrials | 12.1% | |
Information Technology | 23.5% | |
Materials | 4.0% | |
Utilities | 2.3% | |
Other Assets and Liabilities—Net | 0.3% |
Fund Statistics
(as of July 31, 2024)
Fund Net Assets (in millions) | $97,344 |
Number of Portfolio Holdings | 344 |
Portfolio Turnover Rate | 10% |
Where can I find additional information about the Fund?
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2024 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR5702
Item 2: Code of Ethics.
Not applicable.
Item 3: Audit Committee Financial Expert.
Not applicable.
Item 4: Principal Accountant Fees and Services.
Not applicable.
Item 5: Audit Committee of Listed Registrants.
Not applicable.
Item 6: Investments.
Not applicable. The complete schedule of investments is included in the financial statements filed under Item 7 of this Form.
Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies.
Financial Statements | 1 |
Shares | Market Value• ($000) | ||
Common Stocks (99.6%) | |||
Brazil (1.1%) | |||
Petroleo Brasileiro SA | 9,437,125 | 67,740 | |
Canada (1.7%) | |||
Cenovus Energy Inc. | 3,752,951 | 75,547 | |
ARC Resources Ltd. | 1,536,162 | 26,581 | |
102,128 | |||
China (0.3%) | |||
China Longyuan Power Group Corp. Ltd. Class H | 22,094,000 | 19,811 | |
France (10.4%) | |||
TotalEnergies SE | 3,616,781 | 244,011 | |
Engie SA (XPAR) | 13,005,226 | 204,444 | |
TotalEnergies SE ADR | 2,428,372 | 164,595 | |
613,050 | |||
Germany (1.4%) | |||
RWE AG | 2,134,988 | 79,680 | |
India (1.6%) | |||
Power Grid Corp. of India Ltd. | 21,971,358 | 91,515 | |
Italy (3.1%) | |||
Enel SpA | 17,032,441 | 121,597 | |
Tenaris SA ADR | 1,414,411 | 45,035 | |
Tenaris SA | 1,044,045 | 16,566 | |
183,198 | |||
Japan (0.8%) | |||
Kansai Electric Power Co. Inc. | 2,752,100 | 47,104 | |
Norway (1.9%) | |||
Equinor ASA | 2,136,198 | 56,567 | |
Equinor ASA ADR | 2,113,633 | 56,138 | |
112,705 | |||
Russia (0.0%) | |||
*,1 | LUKOIL PJSC ADR | 1,423,477 | — |
Spain (2.6%) | |||
Iberdrola SA (XMAD) | 11,573,271 | 152,862 | |
United Kingdom (13.1%) | |||
Shell plc (XLON) | 9,262,104 | 337,732 | |
Shell plc ADR | 3,103,209 | 227,217 | |
National Grid plc | 12,294,379 | 155,993 | |
Glencore plc | 9,571,990 | 53,114 | |
774,056 | |||
United States (61.6%) | |||
Exxon Mobil Corp. | 4,783,495 | 567,275 | |
Phillips 66 | 1,791,971 | 260,696 | |
Chevron Corp. | 1,591,082 | 255,321 | |
Sempra | 2,745,997 | 219,845 | |
Duke Energy Corp. | 1,952,979 | 213,402 | |
Southern Co. | 2,554,097 | 213,318 | |
American Electric Power Co. Inc. | 2,160,006 | 211,940 | |
Williams Cos. Inc. | 4,460,924 | 191,552 | |
NextEra Energy Inc. | 2,390,146 | 182,583 | |
Edison International | 2,050,519 | 164,062 | |
Targa Resources Corp. | 1,161,812 | 157,170 | |
Cheniere Energy Inc. | 689,902 | 126,004 | |
Exelon Corp. | 3,106,157 | 115,549 |
Shares | Market Value• ($000) | ||
2 | Chesapeake Energy Corp. | 1,297,620 | 99,047 |
EQT Corp. | 2,821,914 | 97,384 | |
Atmos Energy Corp. | 750,800 | 96,012 | |
Diamondback Energy Inc. | 439,878 | 88,992 | |
CenterPoint Energy Inc. | 2,783,932 | 77,254 | |
* | First Solar Inc. | 250,949 | 54,202 |
ConocoPhillips | 477,781 | 53,129 | |
EOG Resources Inc. | 414,172 | 52,517 | |
* | Antero Resources Corp. | 1,588,593 | 46,101 |
Schlumberger NV | 947,762 | 45,767 | |
* | Valaris Ltd. | 509,068 | 40,008 |
3,629,130 | |||
Total Common Stocks (Cost $4,678,965) | 5,872,979 | ||
Temporary Cash Investments (0.8%) | |||
Money Market Fund (0.3%) | |||
3,4 | Vanguard Market Liquidity Fund, 5.390% | 181,900 | 18,188 |
Face Amount ($000) | |||
Repurchase Agreement (0.5%) | |||
NatWest Markets plc, 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $25,604,000, collateralized by U.S. Treasury Note/Bond 1.125%–2.500%, 5/15/40–2/15/46, with a value of $26,112,000) | 25,600 | 25,600 | |
Total Temporary Cash Investments (Cost $43,788) | 43,788 | ||
Total Investments (100.4%) (Cost $4,722,753) | 5,916,767 | ||
Other Assets and Liabilities—Net (-0.4%) | (20,961) | ||
Net Assets (100%) | 5,895,806 | ||
Cost is in $000. |
• | See Note A in Notes to Financial Statements. |
* | Non-income-producing security. |
1 | Security value determined using significant unobservable inputs. |
2 | Includes partial security positions on loan to broker-dealers. The total value of securities on loan is $17,739,000. |
3 | Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield. |
4 | Collateral of $18,127,000 was received for securities on loan. |
ADR—American Depositary Receipt. |
($000s, except shares, footnotes, and per-share amounts) | Amount |
Assets | |
Investments in Securities, at Value1 | |
Unaffiliated Issuers (Cost $4,704,565) | 5,898,579 |
Affiliated Issuers (Cost $18,188) | 18,188 |
Total Investments in Securities | 5,916,767 |
Investment in Vanguard | 167 |
Foreign Currency, at Value (Cost $6,906) | 6,863 |
Receivables for Investment Securities Sold | 7,919 |
Receivables for Accrued Income | 5,718 |
Receivables for Capital Shares Issued | 2,114 |
Total Assets | 5,939,548 |
Liabilities | |
Due to Custodian | 1,968 |
Payables for Investment Securities Purchased | 5,907 |
Collateral for Securities on Loan | 18,127 |
Payables to Investment Advisor | 2,921 |
Payables for Capital Shares Redeemed | 3,885 |
Payables to Vanguard | 474 |
Deferred Foreign Capital Gains Taxes | 10,460 |
Total Liabilities | 43,742 |
Net Assets | 5,895,806 |
1 Includes $17,739,000 of securities on loan. | |
At July 31, 2024, net assets consisted of: | |
Paid-in Capital | 4,209,464 |
Total Distributable Earnings (Loss) | 1,686,342 |
Net Assets | 5,895,806 |
Investor Shares—Net Assets | |
Applicable to 37,508,191 outstanding $.001 par value shares of beneficial interest (unlimited authorization) | 1,891,310 |
Net Asset Value Per Share—Investor Shares | $50.42 |
Admiral Shares—Net Assets | |
Applicable to 42,318,849 outstanding $.001 par value shares of beneficial interest (unlimited authorization) | 4,004,496 |
Net Asset Value Per Share—Admiral Shares | $94.63 |
Six Months Ended July 31, 2024 | |
($000) | |
Investment Income | |
Income | |
Dividends1 | 129,412 |
Interest2 | 1,164 |
Securities Lending—Net | 35 |
Total Income | 130,611 |
Expenses | |
Investment Advisory Fees—Note B | |
Basic Fee | 4,342 |
Performance Adjustment | 1,397 |
The Vanguard Group—Note C | |
Management and Administrative—Investor Shares | 2,111 |
Management and Administrative—Admiral Shares | 2,921 |
Marketing and Distribution—Investor Shares | 49 |
Marketing and Distribution—Admiral Shares | 89 |
Custodian Fees | 54 |
Shareholders’ Reports—Investor Shares | 39 |
Shareholders’ Reports—Admiral Shares | 19 |
Trustees’ Fees and Expenses | 2 |
Other Expenses | 36 |
Total Expenses | 11,059 |
Expenses Paid Indirectly | (16) |
Net Expenses | 11,043 |
Net Investment Income | 119,568 |
Realized Net Gain (Loss) | |
Investment Securities Sold2,3 | 387,272 |
Foreign Currencies | 56 |
Realized Net Gain (Loss) | 387,328 |
Change in Unrealized Appreciation (Depreciation) | |
Investment Securities2,4 | 321,475 |
Foreign Currencies | (282) |
Change in Unrealized Appreciation (Depreciation) | 321,193 |
Net Increase (Decrease) in Net Assets Resulting from Operations | 828,089 |
1 | Dividends are net of foreign withholding taxes of $3,256,000. |
2 | Interest income, realized net gain (loss), and change in unrealized appreciation (depreciation) from an affiliated company of the fund were $0, $3,000, and less than $1,000, respectively. Purchases and sales are for temporary cash investment purposes. |
3 | Realized gain (loss) is net of foreign capital gain taxes of $2,973,000. |
4 | The change in unrealized appreciation (depreciation) is net of the change in deferred foreign capital gains taxes of $926,000. |
Six Months Ended July 31, 2024 | Year Ended January 31, 2024 | ||
($000) | ($000) | ||
Increase (Decrease) in Net Assets | |||
Operations | |||
Net Investment Income | 119,568 | 233,150 | |
Realized Net Gain (Loss) | 387,328 | 783,145 | |
Change in Unrealized Appreciation (Depreciation) | 321,193 | (798,406) | |
Net Increase (Decrease) in Net Assets Resulting from Operations | 828,089 | 217,889 | |
Distributions | |||
Investor Shares | (68,382) | (119,899) | |
Admiral Shares | (140,531) | (249,592) | |
Total Distributions | (208,913) | (369,491) | |
Capital Share Transactions | |||
Investor Shares | (86,776) | (122,683) | |
Admiral Shares | (36,191) | (452,087) | |
Net Increase (Decrease) from Capital Share Transactions | (122,967) | (574,770) | |
Total Increase (Decrease) | 496,209 | (726,372) | |
Net Assets | |||
Beginning of Period | 5,399,597 | 6,125,969 | |
End of Period | 5,895,806 | 5,399,597 |
Investor Shares | ||||||
For a Share Outstanding Throughout Each Period | Six Months Ended July 31, 2024 | Year Ended January 31, | ||||
2024 | 2023 | 2022 | 2021 | 2020 | ||
Net Asset Value, Beginning of Period | $45.21 | $46.43 | $41.64 | $31.66 | $43.28 | $47.85 |
Investment Operations | �� | |||||
Net Investment Income1 | .995 | 1.878 | 2.099 | 1.364 | 1.449 | 1.519 |
Net Realized and Unrealized Gain (Loss) on Investments | 6.000 | .080 | 4.807 | 10.019 | (11.669) | (4.524) |
Total from Investment Operations | 6.995 | 1.958 | 6.906 | 11.383 | (10.220) | (3.005) |
Distributions | ||||||
Dividends from Net Investment Income | (.052) | (1.952) | (2.116) | (1.403) | (1.400) | (1.565) |
Distributions from Realized Capital Gains | (1.733) | (1.226) | — | — | — | — |
Total Distributions | (1.785) | (3.178) | (2.116) | (1.403) | (1.400) | (1.565) |
Net Asset Value, End of Period | $50.42 | $45.21 | $46.43 | $41.64 | $31.66 | $43.28 |
Total Return2 | 15.73% | 4.00% | 16.72% | 36.33% | -23.55% | -6.55% |
Ratios/Supplemental Data | ||||||
Net Assets, End of Period (Millions) | $1,891 | $1,775 | $1,950 | $1,771 | $1,363 | $1,793 |
Ratio of Total Expenses to Average Net Assets3 | 0.44%4 | 0.44%4 | 0.46%4 | 0.41% | 0.37% | 0.32% |
Ratio of Net Investment Income to Average Net Assets | 3.98% | 4.02% | 4.70% | 3.68% | 4.49% | 3.20% |
Portfolio Turnover Rate | 19% | 29% | 16% | 14% | 55% | 48% |
The expense ratio and net investment income ratio for the current period have been annualized. |
1 | Calculated based on average shares outstanding. |
2 | Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees. |
3 | Includes performance-based investment advisory fee increases (decreases) of 0.05%, 0.05%, 0.06%, 0.02%, (0.02%), and (0.06%). |
4 | The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.44%, 0.44% and 0.46% respectively. |
Admiral Shares | ||||||
For a Share Outstanding Throughout Each Period | Six Months Ended July 31, 2024 | Year Ended January 31, | ||||
2024 | 2023 | 2022 | 2021 | 2020 | ||
Net Asset Value, Beginning of Period | $84.83 | $87.12 | $78.12 | $59.39 | $81.18 | $89.77 |
Investment Operations | ||||||
Net Investment Income1 | 1.901 | 3.599 | 4.014 | 2.615 | 2.787 | 2.926 |
Net Realized and Unrealized Gain (Loss) on Investments | 11.267 | .145 | 9.026 | 18.794 | (21.903) | (8.512) |
Total from Investment Operations | 13.168 | 3.744 | 13.040 | 21.409 | (19.116) | (5.586) |
Distributions | ||||||
Dividends from Net Investment Income | (.115) | (3.733) | (4.040) | (2.679) | (2.674) | (3.004) |
Distributions from Realized Capital Gains | (3.253) | (2.301) | — | — | — | — |
Total Distributions | (3.368) | (6.034) | (4.040) | (2.679) | (2.674) | (3.004) |
Net Asset Value, End of Period | $94.63 | $84.83 | $87.12 | $78.12 | $59.39 | $81.18 |
Total Return2 | 15.78% | 4.09% | 16.83% | 36.43% | -23.47% | -6.50% |
Ratios/Supplemental Data | ||||||
Net Assets, End of Period (Millions) | $4,004 | $3,625 | $4,176 | $3,608 | $2,751 | $4,388 |
Ratio of Total Expenses to Average Net Assets3 | 0.36%4 | 0.36%4 | 0.38%4 | 0.33% | 0.29% | 0.24% |
Ratio of Net Investment Income to Average Net Assets | 4.05% | 4.11% | 4.78% | 3.76% | 4.60% | 3.28% |
Portfolio Turnover Rate | 19% | 29% | 16% | 14% | 55% | 48% |
The expense ratio and net investment income ratio for the current period have been annualized. |
1 | Calculated based on average shares outstanding. |
2 | Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees. |
3 | Includes performance-based investment advisory fee increases (decreases) of 0.05%, 0.05%, 0.06%, 0.02%, (0.02%), and (0.06%). |
4 | The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.36%, 0.36%, and 0.38% respectively. |
A. | The following significant accounting policies conform to generally accepted accounting principles for U.S. investment companies. The fund consistently follows such policies in preparing its financial statements. |
B. | Wellington Management Company llp provides investment advisory services to the fund for a fee calculated at an annual percentage rate of average net assets. The basic fee is subject to quarterly adjustments based on the fund's performance relative to the MSCI ACWI Energy + Utilities Index for the preceding three years. For the six months ended July 31, 2024, the investment advisory fee paid represented an effective annual rate of 0.15% of the fund’s average net assets, before a net increase of $1,397,000 (0.05%) based on performance. |
C. | In accordance with the terms of a Funds' Service Agreement (the “FSA”) between Vanguard and the fund, Vanguard furnishes to the fund corporate management, administrative, marketing, and distribution services at Vanguard’s cost of operations (as defined by the FSA). These costs of operations are allocated to the fund based on methods and guidelines approved by the board of trustees and are generally settled twice a month. |
D. | The fund has asked its investment advisor to direct certain security trades, subject to obtaining the best price and execution, to brokers who have agreed to rebate to the fund part of the commissions generated. Such rebates are used solely to reduce the fund’s management and administrative expenses. The fund’s custodian bank has also agreed to reduce its fees when the fund maintains cash on deposit in the non-interest-bearing custody account. For the six months ended July 31, 2024, these arrangements reduced the fund’s management and administrative expenses by $13,000 and custodian fees by $3,000. The total expense reduction represented an effective annual rate of less than 0.01% of the fund’s average net assets. |
E. | Various inputs may be used to determine the value of the fund’s investments. These inputs are summarized in three broad levels for financial statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in those securities. |
Level 1 ($000) | Level 2 ($000) | Level 3 ($000) | Total ($000) | |
Investments | ||||
Assets | ||||
Common Stocks—North and South America | 3,798,998 | — | — | 3,798,998 |
Common Stocks—Other | 492,985 | 1,580,996 | — | 2,073,981 |
Temporary Cash Investments | 18,188 | 25,600 | — | 43,788 |
Total | 4,310,171 | 1,606,596 | — | 5,916,767 |
F. | As of July 31, 2024, gross unrealized appreciation and depreciation for investments based on cost for U.S. federal income tax purposes were as follows: |
Amount ($000) | |
Tax Cost | 4,726,608 |
Gross Unrealized Appreciation | 1,286,086 |
Gross Unrealized Depreciation | (95,927) |
Net Unrealized Appreciation (Depreciation) | 1,190,159 |
G. | During the six months ended July 31, 2024, the fund purchased $1,101,313,000 of investment securities and sold $1,293,518,000 of investment securities, other than temporary cash investments. |
H. | Capital share transactions for each class of shares were: |
Six Months Ended July 31, 2024 | Year Ended January 31, 2024 | ||||
Amount ($000) | Shares (000) | Amount ($000) | Shares (000) | ||
Investor Shares | |||||
Issued | 85,185 | 1,761 | 233,455 | 4,941 | |
Issued in Lieu of Cash Distributions | 63,580 | 1,342 | 110,854 | 2,372 | |
Redeemed | (235,541) | (4,854) | (466,992) | (10,049) | |
Net Increase (Decrease)—Investor Shares | (86,776) | (1,751) | (122,683) | (2,736) | |
Admiral Shares | |||||
Issued | 194,905 | 2,133 | 360,636 | 4,121 | |
Issued in Lieu of Cash Distributions | 126,242 | 1,421 | 221,642 | 2,528 | |
Redeemed | (357,338) | (3,965) | (1,034,365) | (11,853) | |
Net Increase (Decrease)—Admiral Shares | (36,191) | (411) | (452,087) | (5,204) |
I. | Significant market disruptions, such as those caused by pandemics, natural or environmental disasters, war, acts of terrorism, or other events, can adversely affect local and global markets and normal market operations. Any such disruptions could have an adverse impact on the value of the fund’s investments and fund performance. |
J. | Management has determined that no events or transactions occurred subsequent to July 31, 2024, that would require recognition or disclosure in these financial statements. |
Financial Statements | 1 |
Shares | Market Value• ($000) | ||
Common Stocks (97.9%) | |||
Belgium (4.0%) | |||
UCB SA | 6,763,485 | 1,130,140 | |
* | Argenx SE | 1,605,438 | 820,838 |
* | Galapagos NV | 588,698 | 15,738 |
1,966,716 | |||
Brazil (0.0%) | |||
*,1 | Hapvida Participacoes e Investimentos SA | 8,909,471 | 6,411 |
China (0.5%) | |||
* | Legend Biotech Corp. ADR | 1,900,644 | 107,177 |
* | Zai Lab Ltd. | 29,739,200 | 56,301 |
*,2 | Zai Lab Ltd. ADR | 2,814,054 | 53,551 |
Shandong Weigao Group Medical Polymer Co. Ltd. Class H | 77,092,000 | 39,119 | |
256,148 | |||
Denmark (5.1%) | |||
Novo Nordisk A/S Class B | 12,681,229 | 1,680,173 | |
* | Genmab A/S | 1,656,337 | 467,868 |
* | Ascendis Pharma A/S ADR | 2,015,767 | 269,105 |
* | Genmab A/S ADR | 2,285,855 | 64,667 |
2,481,813 | |||
Italy (0.2%) | |||
DiaSorin SpA | 491,960 | 53,658 | |
2 | Stevanato Group SpA | 1,642,580 | 33,969 |
87,627 | |||
Japan (8.2%) | |||
Daiichi Sankyo Co. Ltd. | 36,954,497 | 1,505,070 | |
Chugai Pharmaceutical Co. Ltd. | 17,555,800 | 766,179 | |
3 | Eisai Co. Ltd. | 19,123,817 | 729,304 |
Otsuka Holdings Co. Ltd. | 8,244,600 | 420,213 | |
Astellas Pharma Inc. | 28,362,878 | 328,951 | |
Terumo Corp. | 13,952,800 | 250,151 | |
3,999,868 | |||
Switzerland (4.4%) | |||
Novartis AG (Registered) | 15,884,769 | 1,773,182 | |
* | Galderma Group AG | 3,260,599 | 256,499 |
Tecan Group AG (Registered) | 236,453 | 88,296 | |
2,117,977 | |||
United Kingdom (7.7%) | |||
AstraZeneca plc | 17,326,437 | 2,752,664 | |
GSK plc | 36,708,771 | 712,840 | |
*,2,3 | Immunocore Holdings plc ADR | 3,849,028 | 152,806 |
*,2,3 | Autolus Therapeutics plc ADR | 18,897,503 | 88,629 |
Genus plc | 1,791,160 | 41,975 | |
1 | ConvaTec Group plc | 7,111,753 | 21,428 |
3,770,342 | |||
United States (67.8%) | |||
Eli Lilly & Co. | 4,986,491 | 4,010,485 | |
UnitedHealth Group Inc. | 6,347,754 | 3,657,322 | |
Merck & Co. Inc. | 18,170,387 | 2,055,616 | |
Danaher Corp. | 4,931,523 | 1,366,426 | |
Pfizer Inc. | 41,635,060 | 1,271,535 | |
Thermo Fisher Scientific Inc. | 2,027,979 | 1,243,841 | |
Elevance Health Inc. | 2,238,250 | 1,190,816 | |
* | Alnylam Pharmaceuticals Inc. | 4,927,057 | 1,169,979 |
* | Boston Scientific Corp. | 13,757,254 | 1,016,386 |
* | Biogen Inc. | 4,558,453 | 971,862 |
* | Vertex Pharmaceuticals Inc. | 1,903,278 | 943,493 |
* | Intuitive Surgical Inc. | 1,788,338 | 795,113 |
Shares | Market Value• ($000) | ||
HCA Healthcare Inc. | 1,986,265 | 721,114 | |
* | Edwards Lifesciences Corp. | 11,314,857 | 713,402 |
Abbott Laboratories | 6,610,510 | 700,317 | |
* | Centene Corp. | 8,607,919 | 662,121 |
Stryker Corp. | 1,878,483 | 615,109 | |
Humana Inc. | 1,596,263 | 577,225 | |
* | Regeneron Pharmaceuticals Inc. | 494,868 | 534,057 |
Zoetis Inc. | 2,798,500 | 503,842 | |
Cencora Inc. | 2,056,831 | 489,279 | |
Agilent Technologies Inc. | 3,425,831 | 484,413 | |
* | Moderna Inc. | 3,785,417 | 451,297 |
*,3 | Apellis Pharmaceuticals Inc. | 10,088,600 | 399,509 |
* | Align Technology Inc. | 1,444,261 | 334,895 |
*,3 | Acadia Healthcare Co. Inc. | 4,736,476 | 307,160 |
* | Molina Healthcare Inc. | 849,274 | 289,832 |
* | REVOLUTION Medicines Inc. | 6,030,217 | 275,219 |
* | United Therapeutics Corp. | 842,593 | 263,976 |
* | IQVIA Holdings Inc. | 1,067,102 | 262,753 |
Labcorp Holdings Inc. | 1,153,538 | 248,518 | |
* | Cytokinetics Inc. | 4,067,922 | 240,048 |
*,3 | agilon health Inc. | 34,720,760 | 239,226 |
*,3 | Alkermes plc | 8,601,892 | 235,004 |
* | Ionis Pharmaceuticals Inc. | 4,710,416 | 232,977 |
* | Exact Sciences Corp. | 5,033,812 | 229,945 |
*,3 | Denali Therapeutics Inc. | 8,797,384 | 214,392 |
* | DexCom Inc. | 2,914,285 | 197,647 |
Encompass Health Corp. | 2,095,873 | 194,790 | |
* | Vaxcyte Inc. | 2,321,714 | 183,160 |
* | Sarepta Therapeutics Inc. | 1,264,046 | 179,798 |
*,3 | Amicus Therapeutics Inc. | 16,286,876 | 167,918 |
* | Blueprint Medicines Corp. | 1,511,267 | 163,670 |
* | Guardant Health Inc. | 4,657,527 | 163,619 |
*,3 | Rocket Pharmaceuticals Inc. | 6,490,225 | 157,063 |
*,2,3 | Structure Therapeutics Inc. ADR | 4,040,786 | 151,085 |
* | Option Care Health Inc. | 4,942,098 | 146,731 |
*,3 | Celldex Therapeutics Inc. | 3,848,080 | 146,650 |
*,3 | PTC Therapeutics Inc. | 4,168,888 | 141,117 |
* | Evolent Health Inc. Class A | 5,761,425 | 134,356 |
* | Xenon Pharmaceuticals Inc. | 2,542,337 | 109,651 |
* | Surgery Partners Inc. | 3,609,838 | 109,595 |
* | Qiagen NV | 2,252,052 | 100,194 |
* | Syndax Pharmaceuticals Inc. | 4,249,352 | 96,460 |
*,2 | PACS Group Inc. | 2,322,171 | 83,134 |
* | Apogee Therapeutics Inc. | 1,569,000 | 76,410 |
*,3 | Prothena Corp. plc | 3,007,603 | 70,017 |
* | Akero Therapeutics Inc. | 2,508,425 | 67,050 |
* | Privia Health Group Inc. | 3,229,900 | 66,988 |
* | Kymera Therapeutics Inc. | 1,446,764 | 66,841 |
* | Merus NV | 1,117,644 | 59,280 |
* | Avidity Biosciences Inc. | 1,282,140 | 58,440 |
* | Crinetics Pharmaceuticals Inc. | 960,171 | 51,004 |
* | Glaukos Corp. | 211,205 | 24,747 |
* | Insmed Inc. | 227,800 | 16,572 |
33,102,491 | |||
Total Common Stocks (Cost $26,994,632) | 47,789,393 | ||
Temporary Cash Investments (2.1%) | |||
Money Market Fund (0.2%) | |||
4,5 | Vanguard Market Liquidity Fund, 5.390% | 865,564 | 86,548 |
Face Amount ($000) | Market Value• ($000) | ||
Repurchase Agreements (1.9%) | |||
Bank of America Securities, LLC, 5.350%, 8/1/24 (Dated 7/31/24, Repurchase Value $52,708,000, collateralized by Fannie Mae 2.500%–7.000%, 9/1/27–6/1/54, and Freddie Mac 3.000%–6.000%, 2/1/26–6/1/54, with a value of $53,754,000) | 52,700 | 52,700 | |
Bank of Nova Scotia, 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $114,817,000, collateralized by U.S. Treasury Bill 0.000%, 9/3/2024–6/12/2025, and U.S. Treasury Note/Bond 0.375%–4.625%, 5/15/26–11/15/46, with a value of $117,113,000) | 114,800 | 114,800 | |
Barclays Capital Inc., 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $107,716,000, collateralized by U.S. Treasury Note/Bond 4.125%, 2/15/27, with a value of $109,854,000) | 107,700 | 107,700 | |
BNP Paribas Securities Corp., 5.330%, 8/1/24 (Dated 7/31/24, Repurchase Value $97,314,000, collateralized by U.S. Treasury Bill 0.000%, 8/8/24–9/12/24, U.S. Treasury Inflation Indexed Note/Bond 5.429%–5.504%, 10/31/25–1/31/26, and U.S. Treasury Note/Bond 0.875%–6.500%, 6/30/26–8/15/53, with a value of $99,246,000) | 97,300 | 97,300 | |
BNP Paribas Securities Corp., 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $73,411,000, collateralized by Fannie Mae 1.820%–7.000%, 11/1/29–5/1/54, and Freddie Mac 1.220%–6.500%, 7/1/25–7/1/54, with a value of $74,868,000) | 73,400 | 73,400 | |
Credit Agricole Securities Inc., 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $82,712,000, collateralized by U.S. Treasury Inflation Indexed Note/Bond 0.500%–0.625%, 1/15/26–1/15/28, with a value of $84,354,000) | 82,700 | 82,700 | |
HSBC Bank USA, 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $63,309,000, collateralized by U.S. Treasury Inflation Indexed Note/Bond 2.375%, 1/15/27, and U.S. Treasury Note/Bond 1.375%–2.875%, 8/15/50–5/15/52, with a value of $64,566,000) | 63,300 | 63,300 | |
HSBC Bank USA, 5.350%, 8/1/24 (Dated 7/31/24, Repurchase Value $62,209,000, collateralized by Fannie Mae 2.000%–7.000%, 2/1/51–7/1/54, with a value of $63,444,000) | 62,200 | 62,200 | |
JP Morgan Securities LLC, 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $44,007,000, collateralized by U.S. Treasury Note/Bond 2.875%, 5/15/28, with a value of $44,880,000) | 44,000 | 44,000 | |
Natixis SA, 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $90,413,000, collateralized by U.S. Treasury Bill 0.000%, 8/8/24–1/23/25, U.S. Treasury Inflation Indexed Note/Bond 1.000%–3.625%, 4/15/28–2/15/46, and U.S. Treasury Note/Bond 0.250%–4.875%, 8/31/25–5/15/44, with a value of $92,208,000) | 90,400 | 90,400 | |
Nomura International plc, 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $77,011,000, collateralized by U.S. Treasury Inflation Indexed Note/Bond 0.125%, 7/15/31, and U.S. Treasury Note/Bond 3.750%–4.500%, 5/31/29–11/15/52, with a value of $78,619,000) | 77,000 | 77,000 | |
RBC Capital Markets LLC, 5.330%, 8/1/24 (Dated 7/31/24, Repurchase Value $68,810,000, collateralized by Freddie Mac 3.500%–4.000%, 5/1/47–3/1/53, and U.S. Treasury Note/Bond 4.125%–4.375%, 7/15/27–9/30/27, with a value of $70,176,000) | 68,800 | 68,800 | |
934,300 | |||
Total Temporary Cash Investments (Cost $1,020,847) | 1,020,848 | ||
Total Investments (100.0%) (Cost $28,015,479) | 48,810,241 | ||
Other Assets and Liabilities—Net (0.0%) | 14,049 | ||
Net Assets (100%) | 48,824,290 | ||
Cost is in $000. |
• | See Note A in Notes to Financial Statements. |
* | Non-income-producing security. |
1 | Security exempt from registration under Rule 144A of the Securities Act of 1933. Such securities may be sold in transactions exempt from registration, normally to qualified institutional buyers. At July 31, 2024, the aggregate value was $27,839,000, representing 0.1% of net assets. |
2 | Includes partial security positions on loan to broker-dealers. The total value of securities on loan is $85,323,000. |
3 | Considered an affiliated company of the fund as the fund owns more than 5% of the outstanding voting securities of such company. |
4 | Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield. |
5 | Collateral of $86,502,000 was received for securities on loan. |
ADR—American Depositary Receipt. |
($000s, except shares, footnotes, and per-share amounts) | Amount |
Assets | |
Investments in Securities, at Value1 | |
Unaffiliated Issuers (Cost $24,164,253) | 45,523,813 |
Affiliated Issuers (Cost $3,851,226) | 3,286,428 |
Total Investments in Securities | 48,810,241 |
Investment in Vanguard | 1,383 |
Foreign Currency, at Value (Cost $2,928) | 2,614 |
Receivables for Investment Securities Sold | 75,326 |
Receivables for Accrued Income | 97,167 |
Receivables for Capital Shares Issued | 2,823 |
Total Assets | 48,989,554 |
Liabilities | |
Due to Custodian | 3,526 |
Payables for Investment Securities Purchased | 33,458 |
Collateral for Securities on Loan | 86,502 |
Payables to Investment Advisor | 22,742 |
Payables for Capital Shares Redeemed | 15,892 |
Payables to Vanguard | 3,144 |
Total Liabilities | 165,264 |
Net Assets | 48,824,290 |
1 Includes $85,323,000 of securities on loan. | |
At July 31, 2024, net assets consisted of: | |
Paid-in Capital | 26,539,374 |
Total Distributable Earnings (Loss) | 22,284,916 |
Net Assets | 48,824,290 |
Investor Shares—Net Assets | |
Applicable to 32,958,307 outstanding $.001 par value shares of beneficial interest (unlimited authorization) | 7,461,365 |
Net Asset Value Per Share—Investor Shares | $226.39 |
Admiral Shares—Net Assets | |
Applicable to 433,256,571 outstanding $.001 par value shares of beneficial interest (unlimited authorization) | 41,362,925 |
Net Asset Value Per Share—Admiral Shares | $95.47 |
Six Months Ended July 31, 2024 | |
($000) | |
Investment Income | |
Income | |
Dividends—Unaffiliated Issuers1 | 290,537 |
Dividends—Affiliated Issuers2 | 8,558 |
Interest—Unaffiliated Issuers | 22,074 |
Securities Lending—Net | 52 |
Total Income | 321,221 |
Expenses | |
Investment Advisory Fees—Note B | |
Basic Fee | 33,952 |
Performance Adjustment | 10,845 |
The Vanguard Group—Note C | |
Management and Administrative—Investor Shares | 6,592 |
Management and Administrative—Admiral Shares | 26,508 |
Marketing and Distribution—Investor Shares | 144 |
Marketing and Distribution—Admiral Shares | 547 |
Custodian Fees | 680 |
Shareholders’ Reports—Investor Shares | 82 |
Shareholders’ Reports—Admiral Shares | 85 |
Trustees’ Fees and Expenses | 13 |
Other Expenses | 62 |
Total Expenses | 79,510 |
Expenses Paid Indirectly | (17) |
Net Expenses | 79,493 |
Net Investment Income | 241,728 |
Realized Net Gain (Loss) | |
Investment Securities Sold—Unaffiliated Issuers | 1,392,807 |
Investment Securities Sold—Affiliated Issuers | (129,436) |
Foreign Currencies | (1,010) |
Realized Net Gain (Loss) | 1,262,361 |
Change in Unrealized Appreciation (Depreciation) | |
Investment Securities—Unaffiliated Issuers | 3,722,249 |
Investment Securities—Affiliated Issuers | (450,139) |
Foreign Currencies | (79) |
Change in Unrealized Appreciation (Depreciation) | 3,272,031 |
Net Increase (Decrease) in Net Assets Resulting from Operations | 4,776,120 |
1 | Dividends are net of foreign withholding taxes of $15,142,000. |
2 | Dividends are net of foreign withholding taxes of $1,548,000. |
Six Months Ended July 31, 2024 | Year Ended January 31, 2024 | ||
($000) | ($000) | ||
Increase (Decrease) in Net Assets | |||
Operations | |||
Net Investment Income | 241,728 | 416,405 | |
Realized Net Gain (Loss) | 1,262,361 | 2,900,369 | |
Change in Unrealized Appreciation (Depreciation) | 3,272,031 | (432,502) | |
Net Increase (Decrease) in Net Assets Resulting from Operations | 4,776,120 | 2,884,272 | |
Distributions | |||
Investor Shares | (209,860) | (515,126) | |
Admiral Shares | (1,130,838) | (2,769,814) | |
Total Distributions | (1,340,698) | (3,284,940) | |
Capital Share Transactions | |||
Investor Shares | (363,757) | (145,328) | |
Admiral Shares | (540,898) | (637,906) | |
Net Increase (Decrease) from Capital Share Transactions | (904,655) | (783,234) | |
Total Increase (Decrease) | 2,530,767 | (1,183,902) | |
Net Assets | |||
Beginning of Period | 46,293,523 | 47,477,425 | |
End of Period | 48,824,290 | 46,293,523 |
Investor Shares | ||||||
For a Share Outstanding Throughout Each Period | Six Months Ended July 31, 2024 | Year Ended January 31, | ||||
2024 | 2023 | 2022 | 2021 | 2020 | ||
Net Asset Value, Beginning of Period | $210.61 | $212.59 | $210.54 | $218.60 | $204.57 | $203.34 |
Investment Operations | ||||||
Net Investment Income1 | 1.066 | 1.789 | 1.654 | 1.869 | 2.005 | 2.506 |
Net Realized and Unrealized Gain (Loss) on Investments | 20.872 | 11.217 | 11.988 | 8.949 | 29.203 | 23.326 |
Total from Investment Operations | 21.938 | 13.006 | 13.642 | 10.818 | 31.208 | 25.832 |
Distributions | ||||||
Dividends from Net Investment Income | (.119) | (1.751) | (1.659) | (1.951) | (1.886) | (2.428) |
Distributions from Realized Capital Gains | (6.039) | (13.235) | (9.933) | (16.927) | (15.292) | (22.174) |
Total Distributions | (6.158) | (14.986) | (11.592) | (18.878) | (17.178) | (24.602) |
Net Asset Value, End of Period | $226.39 | $210.61 | $212.59 | $210.54 | $218.60 | $204.57 |
Total Return2 | 10.58% | 6.43% | 6.57% | 4.48% | 16.16% | 13.16% |
Ratios/Supplemental Data | ||||||
Net Assets, End of Period (Millions) | $7,461 | $7,297 | $7,496 | $7,493 | $8,342 | $8,729 |
Ratio of Total Expenses to Average Net Assets3 | 0.38%4 | 0.35%4 | 0.34%4 | 0.30% | 0.32% | 0.32% |
Ratio of Net Investment Income to Average Net Assets | 0.99% | 0.86% | 0.80% | 0.82% | 0.95% | 1.25% |
Portfolio Turnover Rate | 15% | 16% | 19% | 15% | 18% | 18% |
The expense ratio and net investment income ratio for the current period have been annualized. |
1 | Calculated based on average shares outstanding. |
2 | Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees. |
3 | Includes performance-based investment advisory fee increases (decreases) of 0.05%, 0.02%, 0.00%, (0.04%), (0.01%), and (0.02%). |
4 | The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.38%, 0.35% and 0.34% respectively. |
Admiral Shares | ||||||
For a Share Outstanding Throughout Each Period | Six Months Ended July 31, 2024 | Year Ended January 31, | ||||
2024 | 2023 | 2022 | 2021 | 2020 | ||
Net Asset Value, Beginning of Period | $88.81 | $89.64 | $88.77 | $92.17 | $86.27 | $85.75 |
Investment Operations | ||||||
Net Investment Income1 | .469 | .796 | .750 | .830 | .883 | 1.097 |
Net Realized and Unrealized Gain (Loss) on Investments | 8.799 | 4.738 | 5.052 | 3.780 | 12.316 | 9.844 |
Total from Investment Operations | 9.268 | 5.534 | 5.802 | 4.610 | 13.199 | 10.941 |
Distributions | ||||||
Dividends from Net Investment Income | (.062) | (.782) | (.743) | (.870) | (.849) | (1.068) |
Distributions from Realized Capital Gains | (2.546) | (5.582) | (4.189) | (7.140) | (6.450) | (9.353) |
Total Distributions | (2.608) | (6.364) | (4.932) | (8.010) | (7.299) | (10.421) |
Net Asset Value, End of Period | $95.47 | $88.81 | $89.64 | $88.77 | $92.17 | $86.27 |
Total Return2 | 10.61% | 6.48% | 6.63% | 4.53% | 16.21% | 13.22% |
Ratios/Supplemental Data | ||||||
Net Assets, End of Period (Millions) | $41,363 | $38,997 | $39,981 | $39,934 | $40,769 | $38,126 |
Ratio of Total Expenses to Average Net Assets3 | 0.33%4 | 0.30%4 | 0.29%4 | 0.25% | 0.27% | 0.27% |
Ratio of Net Investment Income to Average Net Assets | 1.04% | 0.90% | 0.86% | 0.86% | 0.99% | 1.30% |
Portfolio Turnover Rate | 15% | 16% | 19% | 15% | 18% | 18% |
The expense ratio and net investment income ratio for the current period have been annualized. |
1 | Calculated based on average shares outstanding. |
2 | Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees. |
3 | Includes performance-based investment advisory fee increases (decreases) of 0.05%, 0.02%, 0.00%, (0.04%), (0.01%), and (0.02%). |
4 | The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.33%, 0.30%, and 0.29% respectively. |
A. | The following significant accounting policies conform to generally accepted accounting principles for U.S. investment companies. The fund consistently follows such policies in preparing its financial statements. |
B. | Wellington Management Company llp provides investment advisory services to the fund for a fee calculated at an annual percentage rate of average net assets. The basic fee is subject to quarterly adjustments based on the fund’s performance relative to the MSCI All Country World Health Care Index for the preceding three years. For the six months ended July 31, 2024, the investment advisory fee represented an effective annual basic rate of 0.14% of the fund’s average net assets, before a net increase of $10,845,000 (0.05%) based on performance. |
C. | In accordance with the terms of a Funds' Service Agreement (the “FSA”) between Vanguard and the fund, Vanguard furnishes to the fund corporate management, administrative, marketing, and distribution services at Vanguard’s cost of operations (as defined by the FSA). These costs of operations are allocated to the fund based on methods and guidelines approved by the board of trustees and are generally settled twice a month. |
D. | The fund has asked its investment advisor to direct certain security trades, subject to obtaining the best price and execution, to brokers who have agreed to rebate to the fund part of the commissions generated. Such rebates are used solely to reduce the fund’s management and administrative expenses. The fund’s custodian bank has also agreed to reduce its fees when the fund maintains cash on deposit in the non-interest-bearing custody account. For the six months ended July 31, 2024, these arrangements reduced the fund’s management and administrative expenses by $7,000 and custodian fees by $10,000. The total expense reduction represented an effective annual rate of less than 0.01% of the fund’s average net assets. |
E. | Various inputs may be used to determine the value of the fund’s investments. These inputs are summarized in three broad levels for financial statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in those securities. |
Level 1 ($000) | Level 2 ($000) | Level 3 ($000) | Total ($000) | |
Investments | ||||
Assets | ||||
Common Stocks—North and South America | 33,108,902 | — | — | 33,108,902 |
Common Stocks—Other | 769,904 | 13,910,587 | — | 14,680,491 |
Temporary Cash Investments | 86,548 | 934,300 | — | 1,020,848 |
Total | 33,965,354 | 14,844,887 | — | 48,810,241 |
F. | As of July 31, 2024, gross unrealized appreciation and depreciation for investments based on cost for U.S. federal income tax purposes were as follows: |
Amount ($000) | |
Tax Cost | 28,034,636 |
Gross Unrealized Appreciation | 22,518,202 |
Gross Unrealized Depreciation | (1,742,597) |
Net Unrealized Appreciation (Depreciation) | 20,775,605 |
G. | During the six months ended July 31, 2024, the fund purchased $6,766,287,000 of investment securities and sold $8,963,606,000 of investment securities, other than temporary cash investments. |
H. | Capital share transactions for each class of shares were: |
Six Months Ended July 31, 2024 | Year Ended January 31, 2024 | ||||
Amount ($000) | Shares (000) | Amount ($000) | Shares (000) | ||
Investor Shares | |||||
Issued | 146,801 | 682 | 533,020 | 2,583 | |
Issued in Lieu of Cash Distributions | 197,676 | 923 | 485,637 | 2,364 | |
Redeemed | (708,234) | (3,292) | (1,163,985) | (5,561) | |
Net Increase (Decrease)—Investor Shares | (363,757) | (1,687) | (145,328) | (614) | |
Admiral Shares | |||||
Issued | 409,345 | 4,516 | 829,622 | 9,373 | |
Issued in Lieu of Cash Distributions | 993,472 | 11,007 | 2,430,038 | 28,058 | |
Redeemed | (1,943,715) | (21,383) | (3,897,566) | (44,323) | |
Net Increase (Decrease)—Admiral Shares | (540,898) | (5,860) | (637,906) | (6,892) |
I. | Certain of the fund’s investments were in companies that were considered to be affiliated companies of the fund because the fund owned more than 5% of the outstanding voting securities of the company or the issuer was another member of The Vanguard Group. Transactions during the period in securities of these companies were as follows: |
Current Period Transactions | ||||||||
Jan. 31, 2024 Market Value ($000) | Purchases at Cost ($000) | Proceeds from Securities Sold ($000) | Realized Net Gain (Loss) ($000) | Change in Unrealized App. (Dep.) ($000) | Income ($000) | Capital Gain Distributions Received ($000) | Jul. 31, 2024 Market Value ($000) | |
Acadia Healthcare Co. Inc. | NA1 | 119,059 | — | — | (62,216) | — | — | 307,160 |
agilon health Inc. | 179,707 | 26,464 | — | — | 33,055 | — | — | 239,226 |
Alkermes plc | 232,681 | — | — | — | 2,323 | — | — | 235,004 |
Amicus Therapeutics Inc. | NA1 | 72,450 | — | — | (30,757) | — | — | 167,918 |
Apellis Pharmaceuticals Inc. | 601,469 | 21,679 | — | — | (223,639) | — | — | 399,509 |
Autolus Therapeutics plc ADR | — | 91,206 | — | — | (2,577) | — | — | 88,629 |
Celldex Therapeutics Inc. | NA1 | 65,233 | — | — | 3,241 | — | — | 146,650 |
Denali Therapeutics Inc. | NA1 | 69,515 | — | — | 63,219 | — | — | 214,392 |
Eisai Co. Ltd. | 900,515 | — | — | — | (171,211) | 8,558 | — | 729,304 |
Immunocore Holdings plc ADR | 209,467 | 48,615 | — | — | (105,276) | — | — | 152,806 |
Prothena Corp. plc | NA1 | 14,312 | — | — | (12,268) | — | — | 70,017 |
PTC Therapeutics Inc. | NA1 | 25,395 | — | — | 27,176 | — | — | 141,117 |
Rocket Pharmaceuticals Inc. | NA1 | 57,986 | — | — | (18,488) | — | — | 157,063 |
Sage Therapeutics Inc. | 110,372 | — | 53,615 | (129,435) | 72,678 | — | — | — |
Structure Therapeutics Inc. ADR | 105,169 | 80,705 | — | — | (34,789) | — | — | 151,085 |
Syndax Pharmaceuticals Inc. | 87,069 | — | — | — | 9,391 | — | — | NA2 |
Vanguard Market Liquidity Fund | 14,873 | NA3 | NA3 | (1) | (1) | — | — | 86,548 |
Total | 2,441,322 | 692,619 | 53,615 | (129,436) | (450,139) | 8,558 | — | 3,286,428 |
1 | Not applicable—at January 31, 2024, the issuer was not an affiliated company of the fund. |
2 | Not applicable—at July 31, 2024, the security was still held, but the issuer was no longer an affiliated company of the fund. |
3 | Not applicable—purchases and sales are for temporary cash investment purposes. |
J. | Significant market disruptions, such as those caused by pandemics, natural or environmental disasters, war, acts of terrorism, or other events, can adversely affect local and global markets and normal market operations. Any such disruptions could have an adverse impact on the value of the fund’s investments and fund performance. |
K. | Management has determined that no events or transactions occurred subsequent to July 31, 2024, that would require recognition or disclosure in these financial statements. |
Financial Statements | 1 |
Shares | Market Value• ($000) | ||
Common Stocks (98.3%) | |||
Consumer Discretionary (9.8%) | |||
McDonald's Corp. | 6,342,752 | 1,683,367 | |
TJX Cos. Inc. | 12,185,091 | 1,377,159 | |
NIKE Inc. Class B | 14,704,221 | 1,100,758 | |
Home Depot Inc. | 2,719,150 | 1,001,082 | |
5,162,366 | |||
Consumer Staples (12.8%) | |||
Procter & Gamble Co. | 8,741,996 | 1,405,363 | |
PepsiCo Inc. | 7,942,613 | 1,371,451 | |
Coca-Cola Co. | 19,547,106 | 1,304,574 | |
Diageo plc | 39,163,109 | 1,218,559 | |
Colgate-Palmolive Co. | 10,657,764 | 1,057,144 | |
Costco Wholesale Corp. | 505,622 | 415,621 | |
6,772,712 | |||
Financials (14.8%) | |||
Visa Inc. Class A | 5,939,552 | 1,577,961 | |
Mastercard Inc. Class A | 3,218,172 | 1,492,298 | |
Marsh & McLennan Cos. Inc. | 5,936,976 | 1,321,393 | |
Chubb Ltd. | 4,610,097 | 1,270,819 | |
American Express Co. | 4,212,507 | 1,065,933 | |
S&P Global Inc. | 1,278,401 | 619,679 | |
PNC Financial Services Group Inc. | 2,754,741 | 498,884 | |
7,846,967 | |||
Health Care (19.1%) | |||
UnitedHealth Group Inc. | 3,452,010 | 1,988,910 | |
Danaher Corp. | 6,890,929 | 1,909,339 | |
Stryker Corp. | 5,424,448 | 1,776,235 | |
Abbott Laboratories | 13,069,935 | 1,384,629 | |
Johnson & Johnson | 7,466,831 | 1,178,639 | |
Medtronic plc | 10,936,838 | 878,447 | |
Merck & Co. Inc. | 6,178,373 | 698,959 | |
Pfizer Inc. | 9,527,528 | 290,971 | |
10,106,129 | |||
Industrials (18.5%) | |||
Honeywell International Inc. | 7,757,524 | 1,588,353 | |
Northrop Grumman Corp. | 3,070,733 | 1,487,217 | |
Union Pacific Corp. | 4,933,513 | 1,217,246 | |
Automatic Data Processing Inc. | 4,407,718 | 1,157,555 | |
Canadian National Railway Co. | 9,993,827 | 1,156,929 | |
General Dynamics Corp. | 3,457,703 | 1,032,850 | |
Lockheed Martin Corp. | 1,572,645 | 852,248 | |
United Parcel Service Inc. Class B (XNYS) | 5,713,747 | 744,901 | |
Deere & Co. | 1,469,434 | 546,600 | |
9,783,899 | |||
Information Technology (15.2%) | |||
Microsoft Corp. | 5,121,832 | 2,142,719 | |
Apple Inc. | 8,840,922 | 1,963,392 | |
Texas Instruments Inc. | 7,787,532 | 1,587,177 | |
Accenture plc Class A | 4,686,390 | 1,549,414 | |
Intuit Inc. | 1,209,715 | 783,109 | |
8,025,811 | |||
Materials (5.0%) | |||
Linde plc | 3,578,494 | 1,622,847 | |
Ecolab Inc. | 4,509,957 | 1,040,402 | |
2,663,249 | |||
Real Estate (3.1%) | |||
American Tower Corp. | 4,700,781 | 1,036,052 |
Shares | Market Value• ($000) | ||
Public Storage | 1,990,950 | 589,162 | |
1,625,214 | |||
Total Common Stocks (Cost $26,473,990) | 51,986,347 | ||
Temporary Cash Investments (1.6%) | |||
Money Market Fund (0.0%) | |||
1 | Vanguard Market Liquidity Fund, 5.390% | 262 | 26 |
Face Amount ($000) | |||
Repurchase Agreements (1.6%) | |||
Credit Agricole Securities Inc. 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $189,928,000, collateralized by U.S. Treasury Note/Bond 1.250%, 3/31/28, with a value of $193,698,000) | 189,900 | 189,900 | |
JP Morgan Securities LLC 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $49,007,000, collateralized by U.S. Treasury Note/Bond 4.250%, 2/15/54, with a value of $49,980,000) | 49,000 | 49,000 | |
Natixis SA 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $209,731,000, collateralized by Federal Home Loan Bank 4.000%, 10/24/29, Freddie Mac 2.150%, 7/13/40, U.S. Treasury Bill 0.000%, 8/20/24–1/23/25, U.S. Treasury Inflation Indexed Note/Bond 0.125%–3.625%, 10/15/25–2/15/53, and U.S. Treasury Note/Bond 0.250%–4.250%, 10/31/24–2/15/54, with a value of $213,894,000) | 209,700 | 209,700 | |
NatWest Markets plc 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $186,728,000, collateralized by U.S. Treasury Note/Bond 1.500%–4.500%, 6/15/25–6/30/29, with a value of $190,434,000) | 186,700 | 186,700 | |
Societe Generale 5.340%, 8/1/24 (Dated 7/31/24, Repurchase Value $201,330,000, collateralized by U.S. Treasury Note/Bond 4.375%, 5/15/34, with a value of $205,326,000) | 201,300 | 201,300 | |
836,600 | |||
Total Temporary Cash Investments (Cost $836,626) | 836,626 | ||
Total Investments (99.9%) (Cost $27,310,616) | 52,822,973 | ||
Other Assets and Liabilities—Net (0.1%) | 42,092 | ||
Net Assets (100%) | 52,865,065 | ||
Cost is in $000. |
• | See Note A in Notes to Financial Statements. |
1 | Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield. |
($000s, except shares, footnotes, and per-share amounts) | Amount |
Assets | |
Investments in Securities, at Value | |
Unaffiliated Issuers (Cost $27,310,590) | 52,822,947 |
Affiliated Issuers (Cost $26) | 26 |
Total Investments in Securities | 52,822,973 |
Investment in Vanguard | 1,488 |
Receivables for Accrued Income | 64,011 |
Receivables for Capital Shares Issued | 14,332 |
Total Assets | 52,902,804 |
Liabilities | |
Due to Custodian | 184 |
Payables to Investment Advisor | 9,064 |
Payables for Capital Shares Redeemed | 25,276 |
Payables to Vanguard | 3,215 |
Total Liabilities | 37,739 |
Net Assets | 52,865,065 |
At July 31, 2024, net assets consisted of: | |
Paid-in Capital | 24,409,060 |
Total Distributable Earnings (Loss) | 28,456,005 |
Net Assets | 52,865,065 |
Net Assets | |
Applicable to 1,337,477,443 outstanding $.001 par value shares of beneficial interest (unlimited authorization) | 52,865,065 |
Net Asset Value Per Share | $39.53 |
Six Months Ended July 31, 2024 | |
($000) | |
Investment Income | |
Income | |
Dividends1 | 487,493 |
Interest2 | 22,125 |
Securities Lending—Net | 3 |
Total Income | 509,621 |
Expenses | |
Investment Advisory Fees—Note B | |
Basic Fee | 34,334 |
Performance Adjustment | (10,322) |
The Vanguard Group—Note C | |
Management and Administrative | 34,931 |
Marketing and Distribution | 1,274 |
Custodian Fees | 144 |
Shareholders’ Reports | 266 |
Trustees’ Fees and Expenses | 15 |
Other Expenses | 7 |
Total Expenses | 60,649 |
Expenses Paid Indirectly | (12) |
Net Expenses | 60,637 |
Net Investment Income | 448,984 |
Realized Net Gain (Loss) | |
Investment Securities Sold2 | 2,898,034 |
Foreign Currencies | (330) |
Realized Net Gain (Loss) | 2,897,704 |
Change in Unrealized Appreciation (Depreciation) | |
Investment Securities2 | 39,314 |
Foreign Currencies | 138 |
Change in Unrealized Appreciation (Depreciation) | 39,452 |
Net Increase (Decrease) in Net Assets Resulting from Operations | 3,386,140 |
1 | Dividends are net of foreign withholding taxes of $1,912,000. |
2 | Interest income, realized net gain (loss), and change in unrealized appreciation (depreciation) from an affiliated company of the fund were $0, less than $1,000, and $0, respectively. Purchases and sales are for temporary cash investment purposes. |
Six Months Ended July 31, 2024 | Year Ended January 31, 2024 | ||
($000) | ($000) | ||
Increase (Decrease) in Net Assets | |||
Operations | |||
Net Investment Income | 448,984 | 900,699 | |
Realized Net Gain (Loss) | 2,897,704 | 850,910 | |
Change in Unrealized Appreciation (Depreciation) | 39,452 | 2,728,339 | |
Net Increase (Decrease) in Net Assets Resulting from Operations | 3,386,140 | 4,479,948 | |
Distributions | |||
Total Distributions | (972,237) | (1,212,175) | |
Capital Share Transactions | |||
Issued | 1,345,015 | 3,541,840 | |
Issued in Lieu of Cash Distributions | 857,594 | 1,065,628 | |
Redeemed | (4,304,202) | (8,774,593) | |
Net Increase (Decrease) from Capital Share Transactions | (2,101,593) | (4,167,125) | |
Total Increase (Decrease) | 312,310 | (899,352) | |
Net Assets | |||
Beginning of Period | 52,552,755 | 53,452,107 | |
End of Period | 52,865,065 | 52,552,755 |
For a Share Outstanding Throughout Each Period | Six Months Ended July 31, 2024 | Year Ended January 31, | ||||
2024 | 2023 | 2022 | 2021 | 2020 | ||
Net Asset Value, Beginning of Period | $37.76 | $35.42 | $37.85 | $31.82 | $30.63 | $26.03 |
Investment Operations | ||||||
Net Investment Income1 | .329 | .620 | .596 | .576 | .557 | .536 |
Net Realized and Unrealized Gain (Loss) on Investments | 2.156 | 2.573 | (.893) | 7.593 | 1.572 | 5.499 |
Total from Investment Operations | 2.485 | 3.193 | (.297) | 8.169 | 2.129 | 6.035 |
Distributions | ||||||
Dividends from Net Investment Income | (.337) | (.629) | (.590) | (.574) | (.539) | (.525) |
Distributions from Realized Capital Gains | (.378) | (.224) | (1.543) | (1.565) | (.400) | (.910) |
Total Distributions | (.715) | (.853) | (2.133) | (2.139) | (.939) | (1.435) |
Net Asset Value, End of Period | $39.53 | $37.76 | $35.42 | $37.85 | $31.82 | $30.63 |
Total Return2 | 6.64% | 9.11% | -0.76% | 25.66% | 7.03% | 23.33% |
Ratios/Supplemental Data | ||||||
Net Assets, End of Period (Millions) | $52,865 | $52,553 | $53,452 | $54,186 | $45,099 | $43,024 |
Ratio of Total Expenses to Average Net Assets3 | 0.23%4 | 0.29%5 | 0.30%5 | 0.27% | 0.26% | 0.27% |
Ratio of Net Investment Income to Average Net Assets | 1.66% | 1.74% | 1.68% | 1.56% | 1.85% | 1.82% |
Portfolio Turnover Rate | 7% | 9% | 11% | 15% | 15% | 17% |
The expense ratio and net investment income ratio for the current period have been annualized. |
1 | Calculated based on average shares outstanding. |
2 | Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees. |
3 | Includes performance-based investment advisory fee increases (decreases) of (0.04%), 0.02%, 0.03%, (0.00%), (0.01%), and 0.00%. |
4 | The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.23%. |
5 | The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.29% and 0.30%, respectively. |
A. | The following significant accounting policies conform to generally accepted accounting principles for U.S. investment companies. The fund consistently follows such policies in preparing its financial statements. |
B. | Wellington Management Company llp provides investment advisory services to the fund for a fee calculated at an annual percentage rate of average net assets. The basic fee is subject to quarterly adjustments based on the fund’s performance relative to the NASDAQ US Dividend Achievers Select Index for periods prior to September 20, 2021, and to the current benchmark S&P U.S. Dividend Growers Index, beginning September 20, 2021, for the preceding three years. The benchmark change will be fully phased in by October 2024. For the six months ended July 31, 2024, the investment advisory fee represented an effective annual basic rate of 0.13% of the fund’s average net assets, before a net decrease of $10,322,000 (0.04%) based on performance. |
C. | In accordance with the terms of a Funds' Service Agreement (the “FSA”) between Vanguard and the fund, Vanguard furnishes to the fund corporate management, administrative, marketing, and distribution services at Vanguard’s cost of operations (as defined by the FSA). These costs of operations are allocated to the fund based on methods and guidelines approved by the board of trustees and are generally settled twice a month. |
D. | The fund has asked its investment advisor to direct certain security trades, subject to obtaining the best price and execution, to brokers who have agreed to rebate to the fund part of the commissions generated. Such rebates are used solely to reduce the fund’s management and administrative expenses. For the six months ended July 31, 2024, these arrangements reduced the fund’s expenses by $12,000 (an annual rate of less than 0.01% of average net assets). |
E. | Various inputs may be used to determine the value of the fund’s investments. These inputs are summarized in three broad levels for financial statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in those securities. |
Level 1 ($000) | Level 2 ($000) | Level 3 ($000) | Total ($000) | |
Investments | ||||
Assets | ||||
Common Stocks | 50,767,788 | 1,218,559 | — | 51,986,347 |
Temporary Cash Investments | 26 | 836,600 | — | 836,626 |
Total | 50,767,814 | 2,055,159 | — | 52,822,973 |
F. | As of July 31, 2024, gross unrealized appreciation and depreciation for investments based on cost for U.S. federal income tax purposes were as follows: |
Amount ($000) | |
Tax Cost | 27,335,621 |
Gross Unrealized Appreciation | 25,630,441 |
Gross Unrealized Depreciation | (143,089) |
Net Unrealized Appreciation (Depreciation) | 25,487,352 |
G. | During the six months ended July 31, 2024, the fund purchased $3,865,082,000 of investment securities and sold $6,259,603,000 of investment securities, other than temporary cash investments. |
H. | Capital shares issued and redeemed were: |
Six Months Ended July 31, 2024 | Year Ended January 31, 2024 | ||
Shares (000) | Shares (000) | ||
Issued | 34,935 | 99,872 | |
Issued in Lieu of Cash Distributions | 22,207 | 29,209 | |
Redeemed | (111,593) | (246,375) | |
Net Increase (Decrease) in Shares Outstanding | (54,451) | (117,294) |
I. | Significant market disruptions, such as those caused by pandemics, natural or environmental disasters, war, acts of terrorism, or other events, can adversely affect local and global markets and normal market operations. Any such disruptions could have an adverse impact on the value of the fund’s investments and fund performance. |
J. | Management has determined that no events or transactions occurred subsequent to July 31, 2024, that would require recognition or disclosure in these financial statements. |
Financial Statements | 1 |
Shares | Market Value• ($000) | ||
Common Stocks (99.7%) | |||
Communication Services (0.9%) | |||
Comcast Corp. Class A | 21,422,875 | 884,122 | |
John Wiley & Sons Inc. Class A | 229,638 | 10,965 | |
Cable One Inc. | 24,661 | 10,195 | |
905,282 | |||
Consumer Discretionary (6.0%) | |||
Home Depot Inc. | 5,379,210 | 1,980,410 | |
McDonald's Corp. | 3,893,205 | 1,033,257 | |
Lowe's Cos. Inc. | 3,101,356 | 761,414 | |
NIKE Inc. Class B | 6,579,743 | 492,560 | |
Starbucks Corp. | 6,173,839 | 481,251 | |
DR Horton Inc. | 1,616,014 | 290,769 | |
Tractor Supply Co. | 582,517 | 153,388 | |
Genuine Parts Co. | 753,234 | 110,808 | |
Williams-Sonoma Inc. | 693,684 | 107,299 | |
Domino's Pizza Inc. | 188,171 | 80,669 | |
Pool Corp. | 207,566 | 77,638 | |
Service Corp. International | 785,913 | 62,802 | |
Churchill Downs Inc. | 360,338 | 51,730 | |
Lithia Motors Inc. | 147,818 | 40,847 | |
Thor Industries Inc. | 288,013 | 30,570 | |
Brunswick Corp. | 366,553 | 29,856 | |
Polaris Inc. | 285,281 | 23,758 | |
Graham Holdings Co. Class B | 18,892 | 14,638 | |
Worthington Enterprises Inc. | 163,759 | 8,173 | |
Dillard's Inc. Class A | 18,667 | 7,440 | |
Monro Inc. | 167,342 | 5,157 | |
Shoe Carnival Inc. | 93,384 | 3,966 | |
Haverty Furniture Cos. Inc. | 70,334 | 2,059 | |
Johnson Outdoors Inc. Class A | 36,195 | 1,535 | |
5,851,994 | |||
Consumer Staples (11.4%) | |||
Procter & Gamble Co. | 12,769,344 | 2,052,800 | |
Costco Wholesale Corp. | 2,390,261 | 1,964,795 | |
Walmart Inc. | 23,067,898 | 1,583,380 | |
Coca-Cola Co. | 20,943,114 | 1,397,743 | |
PepsiCo Inc. | 7,427,211 | 1,282,456 | |
Mondelez International Inc. Class A | 7,319,800 | 500,308 | |
Colgate-Palmolive Co. | 4,430,785 | 439,490 | |
Target Corp. | 2,498,529 | 375,804 | |
Sysco Corp. | 2,725,568 | 208,915 | |
Archer-Daniels-Midland Co. | 2,671,083 | 165,634 | |
Hershey Co. | 797,609 | 157,512 | |
Kroger Co. | 2,615,702 | 142,556 | |
Church & Dwight Co. Inc. | 1,320,520 | 129,424 | |
McCormick & Co. Inc. | 1,359,840 | 104,721 | |
Tyson Foods Inc. Class A | 1,537,416 | 93,629 | |
Clorox Co. | 670,643 | 88,478 | |
Casey's General Stores Inc. | 200,821 | 77,886 | |
J M Smucker Co. | 574,302 | 67,739 | |
Hormel Foods Corp. | 1,567,623 | 50,336 | |
Brown-Forman Corp. Class B | 980,002 | 44,257 | |
Ingredion Inc. | 355,169 | 44,172 | |
Flowers Foods Inc. | 1,035,656 | 23,323 | |
Lancaster Colony Corp. | 109,730 | 21,184 | |
WD-40 Co. | 73,242 | 19,161 | |
J & J Snack Foods Corp. | 83,219 | 14,039 | |
Andersons Inc. | 172,489 | 9,406 | |
SpartanNash Co. | 180,520 | 3,813 |
Shares | Market Value• ($000) | ||
Tootsie Roll Industries Inc. | 97,699 | 3,013 | |
11,065,974 | |||
Energy (3.4%) | |||
Exxon Mobil Corp. | 24,442,260 | 2,898,608 | |
Phillips 66 | 2,342,976 | 340,856 | |
Texas Pacific Land Corp. | 100,500 | 84,912 | |
3,324,376 | |||
Financials (20.2%) | |||
JPMorgan Chase & Co. | 15,510,739 | 3,300,685 | |
Visa Inc. Class A | 8,124,840 | 2,158,526 | |
Mastercard Inc. Class A | 4,451,171 | 2,064,053 | |
Bank of America Corp. | 36,741,712 | 1,481,058 | |
Goldman Sachs Group Inc. | 1,741,504 | 886,478 | |
S&P Global Inc. | 1,743,266 | 845,013 | |
BlackRock Inc. | 754,423 | 661,252 | |
Chubb Ltd. | 2,207,597 | 608,546 | |
Marsh & McLennan Cos. Inc. | 2,666,524 | 593,488 | |
Intercontinental Exchange Inc. | 3,096,373 | 469,286 | |
PNC Financial Services Group Inc. | 2,150,431 | 389,443 | |
Moody's Corp. | 848,214 | 387,193 | |
Aon plc Class A (XNYS) | 1,174,324 | 385,777 | |
CME Group Inc. | 1,944,629 | 376,694 | |
Arthur J Gallagher & Co. | 1,175,299 | 333,186 | |
Aflac Inc. | 2,820,275 | 268,998 | |
Travelers Cos. Inc. | 1,237,834 | 267,917 | |
Bank of New York Mellon Corp. | 4,090,473 | 266,167 | |
MetLife Inc. | 3,267,591 | 251,114 | |
Allstate Corp. | 1,421,077 | 243,175 | |
Ameriprise Financial Inc. | 541,841 | 233,030 | |
Discover Financial Services | 1,353,656 | 194,913 | |
Hartford Financial Services Group Inc. | 1,609,940 | 178,575 | |
Fifth Third Bancorp | 3,694,179 | 156,412 | |
Nasdaq Inc. | 2,254,178 | 152,563 | |
State Street Corp. | 1,663,123 | 141,316 | |
Brown & Brown Inc. | 1,279,338 | 127,205 | |
Raymond James Financial Inc. | 1,005,966 | 116,692 | |
Cincinnati Financial Corp. | 846,388 | 110,555 | |
Cboe Global Markets Inc. | 568,223 | 104,275 | |
Principal Financial Group Inc. | 1,165,451 | 94,996 | |
W R Berkley Corp. | 1,645,739 | 90,730 | |
FactSet Research Systems Inc. | 205,367 | 84,835 | |
Reinsurance Group of America Inc. | 355,139 | 80,059 | |
Fidelity National Financial Inc. | 1,398,972 | 77,517 | |
Jack Henry & Associates Inc. | 393,828 | 67,534 | |
RenaissanceRe Holdings Ltd. | 283,930 | 65,846 | |
Erie Indemnity Co. Class A | 134,866 | 59,496 | |
Unum Group | 972,501 | 55,948 | |
Assurant Inc. | 284,470 | 49,745 | |
Evercore Inc. Class A | 191,700 | 48,000 | |
Old Republic International Corp. | 1,372,625 | 47,520 | |
Primerica Inc. | 185,158 | 46,617 | |
American Financial Group Inc. | 352,954 | 46,223 | |
MarketAxess Holdings Inc. | 204,939 | 45,810 | |
Morningstar Inc. | 141,221 | 44,859 | |
Globe Life Inc. | 451,485 | 41,871 | |
Zions Bancorp NA | 801,294 | 41,403 | |
Commerce Bancshares Inc. | 638,098 | 41,291 | |
SouthState Corp. | 412,274 | 40,803 | |
Cullen/Frost Bankers Inc. | 346,655 | 40,579 | |
Wintrust Financial Corp. | 351,731 | 38,057 | |
Prosperity Bancshares Inc. | 519,019 | 37,639 | |
SEI Investments Co. | 539,367 | 36,591 | |
First American Financial Corp. | 558,702 | 33,846 | |
RLI Corp. | 217,652 | 32,776 | |
Cadence Bank | 989,093 | 32,512 | |
Axis Capital Holdings Ltd. | 415,767 | 31,494 | |
Selective Insurance Group Inc. | 328,121 | 29,636 | |
Home BancShares Inc. | 1,004,492 | 28,457 | |
Hanover Insurance Group Inc. | 194,620 | 26,758 |
Shares | Market Value• ($000) | ||
First Financial Bankshares Inc. | 690,333 | 26,550 | |
Bank OZK | 565,745 | 26,528 | |
UMB Financial Corp. | 236,566 | 24,134 | |
Assured Guaranty Ltd. | 281,615 | 23,197 | |
CNO Financial Group Inc. | 601,903 | 20,982 | |
Atlantic Union Bankshares Corp. | 482,690 | 19,930 | |
International Bancshares Corp. | 290,385 | 19,584 | |
WSFS Financial Corp. | 329,642 | 18,621 | |
Community Financial System Inc. | 289,632 | 17,865 | |
Independent Bank Corp. (XNGS) | 237,716 | 15,250 | |
BOK Financial Corp. | 147,903 | 15,210 | |
First Merchants Corp. | 321,555 | 12,975 | |
NBT Bancorp Inc. | 254,193 | 12,461 | |
Cohen & Steers Inc. | 143,921 | 12,351 | |
Towne Bank | 367,611 | 12,219 | |
Federal Agricultural Mortgage Corp. Class C | 51,020 | 10,521 | |
City Holding Co. | 80,304 | 9,789 | |
Lakeland Financial Corp. | 136,849 | 9,378 | |
Stock Yards Bancorp Inc. | 142,426 | 8,862 | |
TriCo Bancshares | 181,668 | 8,453 | |
BancFirst Corp. | 76,885 | 8,260 | |
Horace Mann Educators Corp. | 220,345 | 7,617 | |
Westamerica BanCorp | 139,977 | 7,553 | |
German American Bancorp Inc. | 157,059 | 6,179 | |
1st Source Corp. | 94,017 | 5,975 | |
AMERISAFE Inc. | 104,704 | 4,971 | |
First Mid Bancshares Inc. | 120,820 | 4,638 | |
First Community Bankshares Inc. | 91,033 | 4,076 | |
Southern Missouri Bancorp Inc. | 53,039 | 3,034 | |
Great Southern Bancorp Inc. | 47,646 | 2,983 | |
Cass Information Systems Inc. | 65,515 | 2,813 | |
1 | Hingham Institution for Savings | 10,259 | 2,551 |
19,678,543 | |||
Health Care (15.9%) | |||
UnitedHealth Group Inc. | 4,971,389 | 2,864,315 | |
Johnson & Johnson | 12,999,798 | 2,052,018 | |
AbbVie Inc. | 9,538,503 | 1,767,675 | |
Merck & Co. Inc. | 13,681,280 | 1,547,763 | |
Abbott Laboratories | 9,391,557 | 994,942 | |
Danaher Corp. | 3,560,264 | 986,478 | |
Amgen Inc. | 2,898,095 | 963,530 | |
Elevance Health Inc. | 1,255,339 | 667,878 | |
Stryker Corp. | 1,830,937 | 599,540 | |
Medtronic plc | 7,176,168 | 576,390 | |
Zoetis Inc. | 2,464,572 | 443,722 | |
McKesson Corp. | 711,005 | 438,704 | |
Becton Dickinson & Co. | 1,567,499 | 377,861 | |
Humana Inc. | 655,673 | 237,098 | |
Cencora Inc. | 900,487 | 214,208 | |
ResMed Inc. | 793,968 | 169,314 | |
Cardinal Health Inc. | 1,332,389 | 134,345 | |
STERIS plc | 534,108 | 127,524 | |
West Pharmaceutical Services Inc. | 393,503 | 120,479 | |
Quest Diagnostics Inc. | 608,480 | 86,587 | |
Chemed Corp. | 81,482 | 46,458 | |
Ensign Group Inc. | 307,037 | 43,215 | |
Perrigo Co. plc | 733,794 | 20,744 | |
National HealthCare Corp. | 73,213 | 9,969 | |
LeMaitre Vascular Inc. | 106,980 | 9,295 | |
Embecta Corp. | 304,033 | 4,764 | |
Atrion Corp. | 7,023 | 3,219 | |
15,508,035 | |||
Industrials (12.1%) | |||
Caterpillar Inc. | 2,646,754 | 916,306 | |
Union Pacific Corp. | 3,293,954 | 812,717 | |
Honeywell International Inc. | 3,517,136 | 720,134 | |
Eaton Corp. plc | 2,159,290 | 658,130 | |
Lockheed Martin Corp. | 1,184,499 | 641,904 | |
Automatic Data Processing Inc. | 2,213,069 | 581,196 |
Shares | Market Value• ($000) | ||
Waste Management Inc. | 1,971,097 | 399,463 | |
CSX Corp. | 10,557,564 | 370,570 | |
General Dynamics Corp. | 1,224,964 | 365,909 | |
Northrop Grumman Corp. | 755,094 | 365,707 | |
Illinois Tool Works Inc. | 1,476,533 | 365,117 | |
Emerson Electric Co. | 3,081,174 | 360,836 | |
Cintas Corp. | 468,041 | 357,555 | |
L3Harris Technologies Inc. | 1,024,501 | 232,449 | |
WW Grainger Inc. | 236,189 | 230,712 | |
Paychex Inc. | 1,737,136 | 222,388 | |
Fastenal Co. | 3,088,508 | 218,512 | |
Cummins Inc. | 738,537 | 215,505 | |
Republic Services Inc. | 1,105,395 | 214,800 | |
Xylem Inc. | 1,309,738 | 174,850 | |
Rockwell Automation Inc. | 616,324 | 171,739 | |
Dover Corp. | 742,419 | 136,798 | |
Broadridge Financial Solutions Inc. | 637,847 | 136,499 | |
Veralto Corp. | 1,186,510 | 126,435 | |
Hubbell Inc. | 289,986 | 114,733 | |
Carlisle Cos. Inc. | 257,138 | 107,633 | |
Booz Allen Hamilton Holding Corp. | 704,987 | 101,032 | |
Lennox International Inc. | 173,030 | 100,963 | |
Expeditors International of Washington Inc. | 763,437 | 95,292 | |
Masco Corp. | 1,215,954 | 94,662 | |
Watsco Inc. | 187,238 | 91,651 | |
Stanley Black & Decker Inc. | 829,112 | 87,571 | |
IDEX Corp. | 409,119 | 85,293 | |
Snap-on Inc. | 284,509 | 81,663 | |
RB Global Inc. (XTSE) | 992,659 | 79,045 | |
Pentair plc | 897,744 | 78,885 | |
HEICO Corp. Class A | 409,527 | 77,855 | |
Graco Inc. | 912,816 | 77,635 | |
JB Hunt Transport Services Inc. | 440,441 | 76,262 | |
Nordson Corp. | 293,265 | 73,413 | |
Allegion plc | 472,525 | 64,646 | |
Comfort Systems USA Inc. | 193,112 | 64,194 | |
Lincoln Electric Holdings Inc. | 307,705 | 63,206 | |
ITT Inc. | 444,152 | 62,830 | |
Huntington Ingalls Industries Inc. | 213,733 | 59,841 | |
Regal Rexnord Corp. | 358,797 | 57,651 | |
CH Robinson Worldwide Inc. | 630,878 | 56,180 | |
A O Smith Corp. | 653,316 | 55,558 | |
Toro Co. | 561,607 | 53,763 | |
HEICO Corp. | 216,839 | 52,332 | |
Donaldson Co. Inc. | 651,836 | 48,770 | |
Applied Industrial Technologies Inc. | 208,924 | 45,585 | |
UFP Industries Inc. | 332,460 | 43,861 | |
Simpson Manufacturing Co. Inc. | 227,998 | 43,796 | |
Oshkosh Corp. | 354,197 | 38,484 | |
MSA Safety Inc. | 199,954 | 37,721 | |
Robert Half Inc. | 567,015 | 36,397 | |
Ryder System Inc. | 237,036 | 33,223 | |
AGCO Corp. | 336,547 | 31,777 | |
Watts Water Technologies Inc. Class A | 148,087 | 30,731 | |
Timken Co. | 351,745 | 30,584 | |
Exponent Inc. | 274,163 | 29,083 | |
Air Lease Corp. | 555,133 | 27,546 | |
GATX Corp. | 192,181 | 26,809 | |
Matson Inc. | 184,956 | 24,546 | |
Franklin Electric Co. Inc. | 215,345 | 22,960 | |
Kadant Inc. | 63,353 | 22,268 | |
ManpowerGroup Inc. | 258,547 | 19,800 | |
ABM Industries Inc. | 354,650 | 19,704 | |
Insperity Inc. | 191,656 | 19,687 | |
Brady Corp. Class A | 241,492 | 17,293 | |
Hillenbrand Inc. | 375,707 | 16,618 | |
Griffon Corp. | 215,985 | 15,564 | |
McGrath RentCorp. | 133,126 | 14,621 | |
HNI Corp. | 252,608 | 13,881 | |
Standex International Corp. | 63,992 | 11,954 |
Shares | Market Value• ($000) | ||
Tennant Co. | 102,000 | 10,984 | |
Apogee Enterprises Inc. | 118,078 | 8,105 | |
Lindsay Corp. | 58,359 | 7,353 | |
CSG Systems International Inc. | 154,259 | 7,225 | |
Gorman-Rupp Co. | 129,722 | 5,359 | |
Hyster-Yale Inc. | 59,672 | 4,878 | |
Matthews International Corp. Class A | 163,834 | 4,743 | |
11,781,930 | |||
Information Technology (23.5%) | |||
Apple Inc. | 19,972,204 | 4,435,427 | |
Broadcom Inc. | 23,470,548 | 3,771,248 | |
Microsoft Corp. | 8,951,732 | 3,744,957 | |
Oracle Corp. | 8,581,639 | 1,196,709 | |
Accenture plc Class A | 3,398,971 | 1,123,768 | |
QUALCOMM Inc. | 6,021,687 | 1,089,624 | |
Cisco Systems Inc. | 21,803,940 | 1,056,401 | |
Texas Instruments Inc. | 4,912,873 | 1,001,293 | |
Intuit Inc. | 1,513,875 | 980,007 | |
International Business Machines Corp. | 4,950,795 | 951,246 | |
Analog Devices Inc. | 2,691,565 | 622,774 | |
KLA Corp. | 730,933 | 601,609 | |
Amphenol Corp. Class A | 6,471,271 | 415,844 | |
Motorola Solutions Inc. | 900,792 | 359,344 | |
Roper Technologies Inc. | 578,161 | 314,953 | |
Microchip Technology Inc. | 2,922,240 | 259,436 | |
TE Connectivity Ltd. | 1,664,615 | 256,900 | |
HP Inc. | 4,649,273 | 167,792 | |
Corning Inc. | 4,164,578 | 166,625 | |
CDW Corp. | 725,991 | 158,346 | |
Amdocs Ltd. | 631,347 | 55,224 | |
Littelfuse Inc. | 133,714 | 35,716 | |
Badger Meter Inc. | 157,832 | 32,539 | |
Avnet Inc. | 491,064 | 26,400 | |
Power Integrations Inc. | 306,780 | 22,407 | |
22,846,589 | |||
Materials (4.0%) | |||
Linde plc | 2,596,825 | 1,177,660 | |
Sherwin-Williams Co. | 1,260,011 | 442,012 | |
Ecolab Inc. | 1,372,853 | 316,703 | |
Air Products and Chemicals Inc. | 1,200,002 | 316,621 | |
Nucor Corp. | 1,295,259 | 211,050 | |
Vulcan Materials Co. | 714,520 | 196,143 | |
PPG Industries Inc. | 1,271,820 | 161,496 | |
Steel Dynamics Inc. | 797,328 | 106,220 | |
Packaging Corp. of America | 484,476 | 96,832 | |
Reliance Inc. | 309,881 | 94,377 | |
Avery Dennison Corp. | 435,248 | 94,375 | |
RPM International Inc. | 696,609 | 84,610 | |
Celanese Corp. | 543,623 | 76,732 | |
Eastman Chemical Co. | 641,400 | 66,276 | |
Albemarle Corp. | 634,470 | 59,431 | |
AptarGroup Inc. | 355,478 | 52,248 | |
Royal Gold Inc. | 355,584 | 49,113 | |
Balchem Corp. | 175,943 | 31,223 | |
Cabot Corp. | 296,881 | 29,774 | |
Sonoco Products Co. | 530,153 | 28,586 | |
Ashland Inc. | 275,297 | 26,607 | |
Westlake Corp. | 172,996 | 25,579 | |
HB Fuller Co. | 293,348 | 25,287 | |
Silgan Holdings Inc. | 438,429 | 22,548 | |
Avient Corp. | 493,635 | 22,332 | |
Innospec Inc. | 134,660 | 17,659 | |
Quaker Chemical Corp. | 75,354 | 13,682 | |
Materion Corp. | 111,698 | 13,452 | |
Hawkins Inc. | 102,086 | 10,607 | |
Stepan Co. | 116,088 | 9,825 | |
Worthington Steel Inc. | 163,283 | 6,510 | |
3,885,570 |
Shares | Market Value• ($000) | ||
Utilities (2.3%) | |||
NextEra Energy Inc. | 11,096,003 | 847,624 | |
Sempra | 3,417,219 | 273,583 | |
Xcel Energy Inc. | 3,001,114 | 174,905 | |
American Water Works Co. Inc. | 1,051,992 | 149,762 | |
DTE Energy Co. | 1,116,487 | 134,570 | |
CMS Energy Corp. | 1,598,796 | 103,602 | |
Atmos Energy Corp. | 802,466 | 102,619 | |
Alliant Energy Corp. | 1,385,695 | 77,128 | |
AES Corp. | 3,837,184 | 68,263 | |
Essential Utilities Inc. | 1,363,510 | 55,427 | |
National Fuel Gas Co. | 497,563 | 29,152 | |
IDACORP Inc. | 274,136 | 26,797 | |
New Jersey Resources Corp. | 528,134 | 24,690 | |
Otter Tail Corp. | 225,769 | 21,881 | |
MGE Energy Inc. | 195,549 | 17,177 | |
American States Water Co. | 201,800 | 16,655 | |
California Water Service Group | 308,783 | 16,508 | |
Chesapeake Utilities Corp. | 117,651 | 13,886 | |
SJW Group | 155,839 | 9,445 | |
Middlesex Water Co. | 93,302 | 6,203 | |
York Water Co. | 76,786 | 3,172 | |
Artesian Resources Corp. Class A | 51,376 | 2,012 | |
2,175,061 | |||
Total Common Stocks (Cost $64,769,599) | 97,023,354 | ||
Temporary Cash Investments (0.2%) | |||
Money Market Fund (0.2%) | |||
2,3 | Vanguard Market Liquidity Fund, 5.390% (Cost $247,580) | 2,476,323 | 247,608 |
Total Investments (99.9%) (Cost $65,017,179) | 97,270,962 | ||
Other Assets and Liabilities—Net (0.1%) | 73,402 | ||
Net Assets (100%) | 97,344,364 | ||
Cost is in $000. |
• | See Note A in Notes to Financial Statements. |
1 | Includes partial security positions on loan to broker-dealers. The total value of securities on loan is $1,343,000. |
2 | Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield. |
3 | Collateral of $1,388,000 was received for securities on loan. |
Futures Contracts | ||||
($000) | ||||
Expiration | Number of Long (Short) Contracts | Notional Amount | Value and Unrealized Appreciation (Depreciation) | |
Long Futures Contracts | ||||
E-mini S&P 500 Index | September 2024 | 545 | 151,456 | (62) |
Over-the-Counter Total Return Swaps | ||||||
Reference Entity | Termination Date | Counterparty | Notional Amount ($000) | Floating Interest Rate Received (Paid)1 (%) | Value and Unrealized Appreciation ($000) | Value and Unrealized (Depreciation) ($000) |
Kroger Co. | 1/31/25 | GSI | 52,120 | (5.326) | 2,249 | — |
Visa Inc. Class A | 8/30/24 | BANA | 118,223 | (5.231) | — | (526) |
2,249 | (526) |
1 | Based on Overnight Bank Funding Rate as of the most recent reset date. Floating interest payment received/paid monthly. |
BANA—Bank of America, N.A. | |
GSI—Goldman Sachs International. |
($000s, except shares, footnotes, and per-share amounts) | Amount |
Assets | |
Investments in Securities, at Value1 | |
Unaffiliated Issuers (Cost $64,769,599) | 97,023,354 |
Affiliated Issuers (Cost $247,580) | 247,608 |
Total Investments in Securities | 97,270,962 |
Investment in Vanguard | 2,708 |
Cash | 85 |
Cash Collateral Pledged—Futures Contracts | 7,140 |
Cash Collateral Pledged—Over-the-Counter Swap Contracts | 230 |
Receivables for Investment Securities Sold | 2,732 |
Receivables for Accrued Income | 77,887 |
Receivables for Capital Shares Issued | 3,954 |
Variation Margin Receivable—Futures Contracts | 2,330 |
Unrealized Appreciation—Over-the-Counter Swap Contracts | 2,249 |
Total Assets | 97,370,277 |
Liabilities | |
Payables for Investment Securities Purchased | 15,361 |
Collateral for Securities on Loan | 1,388 |
Payables for Capital Shares Redeemed | 5,974 |
Payables to Vanguard | 2,664 |
Unrealized Depreciation—Over-the-Counter Swap Contracts | 526 |
Total Liabilities | 25,913 |
Net Assets | 97,344,364 |
1 Includes $1,343,000 of securities on loan. | |
At July 31, 2024, net assets consisted of: | |
Paid-in Capital | 66,529,460 |
Total Distributable Earnings (Loss) | 30,814,904 |
Net Assets | 97,344,364 |
ETF Shares—Net Assets | |
Applicable to 432,213,118 outstanding $.001 par value shares of beneficial interest (unlimited authorization) | 82,051,334 |
Net Asset Value Per Share—ETF Shares | $189.84 |
Admiral Shares—Net Assets | |
Applicable to 296,842,421 outstanding $.001 par value shares of beneficial interest (unlimited authorization) | 15,293,030 |
Net Asset Value Per Share—Admiral Shares | $51.52 |
Six Months Ended July 31, 2024 | |
($000) | |
Investment Income | |
Income | |
Dividends1 | 869,194 |
Interest2 | 7,253 |
Securities Lending—Net | 617 |
Total Income | 877,064 |
Expenses | |
The Vanguard Group—Note B | |
Investment Advisory Services | 876 |
Management and Administrative—ETF Shares | 20,207 |
Management and Administrative—Admiral Shares | 5,266 |
Marketing and Distribution—ETF Shares | 1,338 |
Marketing and Distribution—Admiral Shares | 283 |
Custodian Fees | 247 |
Shareholders’ Reports—ETF Shares | 745 |
Shareholders’ Reports—Admiral Shares | 90 |
Trustees’ Fees and Expenses | 26 |
Other Expenses | 7 |
Total Expenses | 29,085 |
Expenses Paid Indirectly | (19) |
Net Expenses | 29,066 |
Net Investment Income | 847,998 |
Realized Net Gain (Loss) | |
Investment Securities Sold2,3 | 2,148,000 |
Futures Contracts | 22,801 |
Swap Contracts | (791) |
Realized Net Gain (Loss) | 2,170,010 |
Change in Unrealized Appreciation (Depreciation) | |
Investment Securities2 | 6,696,270 |
Futures Contracts | (2,857) |
Swap Contracts | 2,228 |
Change in Unrealized Appreciation (Depreciation) | 6,695,641 |
Net Increase (Decrease) in Net Assets Resulting from Operations | 9,713,649 |
1 | Dividends are net of foreign withholding taxes of $40,000. |
2 | Interest income, realized net gain (loss), and change in unrealized appreciation (depreciation) from an affiliated company of the fund were $7,025,000, less than $1,000, and ($3,000), respectively. Purchases and sales are for temporary cash investment purposes. |
3 | Includes $2,383,778,000 of net gain (loss) resulting from in-kind redemptions. |
Six Months Ended July 31, 2024 | Year Ended January 31, 2024 | ||
($000) | ($000) | ||
Increase (Decrease) in Net Assets | |||
Operations | |||
Net Investment Income | 847,998 | 1,612,939 | |
Realized Net Gain (Loss) | 2,170,010 | 1,197,892 | |
Change in Unrealized Appreciation (Depreciation) | 6,695,641 | 7,178,539 | |
Net Increase (Decrease) in Net Assets Resulting from Operations | 9,713,649 | 9,989,370 | |
Distributions | |||
ETF Shares | (720,291) | (1,372,849) | |
Admiral Shares | (133,111) | (255,095) | |
Total Distributions | (853,402) | (1,627,944) | |
Capital Share Transactions | |||
ETF Shares | 597,708 | 879,631 | |
Admiral Shares | (67,305) | 179,423 | |
Net Increase (Decrease) from Capital Share Transactions | 530,403 | 1,059,054 | |
Total Increase (Decrease) | 9,390,650 | 9,420,480 | |
Net Assets | |||
Beginning of Period | 87,953,714 | 78,533,234 | |
End of Period | 97,344,364 | 87,953,714 |
ETF Shares | ||||||
For a Share Outstanding Throughout Each Period | Six Months Ended July 31, 2024 | Year Ended January 31, | ||||
2024 | 2023 | 2022 | 2021 | 2020 | ||
Net Asset Value, Beginning of Period | $172.53 | $156.26 | $162.69 | $137.11 | $125.38 | $104.09 |
Investment Operations | ||||||
Net Investment Income1 | 1.657 | 3.185 | 2.982 | 2.736 | 2.299 | 2.214 |
Net Realized and Unrealized Gain (Loss) on Investments | 17.321 | 16.293 | (6.439) | 25.504 | 11.728 | 21.210 |
Total from Investment Operations | 18.978 | 19.478 | (3.457) | 28.240 | 14.027 | 23.424 |
Distributions | ||||||
Dividends from Net Investment Income | (1.668) | (3.208) | (2.973) | (2.660) | (2.297) | (2.134) |
Distributions from Realized Capital Gains | — | — | — | — | — | — |
Total Distributions | (1.668) | (3.208) | (2.973) | (2.660) | (2.297) | (2.134) |
Net Asset Value, End of Period | $189.84 | $172.53 | $156.26 | $162.69 | $137.11 | $125.38 |
Total Return | 11.04% | 12.66% | -2.02% | 20.71% | 11.44% | 22.68% |
Ratios/Supplemental Data | ||||||
Net Assets, End of Period (Millions) | $82,051 | $73,991 | $66,062 | $65,589 | $51,842 | $42,217 |
Ratio of Total Expenses to Average Net Assets | 0.06%2 | 0.06%2 | 0.06%2 | 0.06% | 0.06% | 0.06% |
Ratio of Net Investment Income to Average Net Assets | 1.78% | 1.99% | 1.96% | 1.74% | 1.84% | 1.90% |
Portfolio Turnover Rate3 | 10% | 13% | 12% | 26% | 25% | 14% |
The expense ratio and net investment income ratio for the current period have been annualized. |
1 | Calculated based on average shares outstanding. |
2 | The ratio of expenses to average net assets for the period net of reduction from custody fee offset arrangements was 0.06%. |
3 | Excludes the value of portfolio securities received or delivered as a result of in-kind purchases or redemptions of the fund’s capital shares, including ETF Creation Units. |
Admiral Shares | ||||||
For a Share Outstanding Throughout Each Period | Six Months Ended July 31, 2024 | Year Ended January 31, | ||||
2024 | 2023 | 2022 | 2021 | 2020 | ||
Net Asset Value, Beginning of Period | $46.82 | $42.41 | $44.15 | $37.21 | $34.03 | $28.25 |
Investment Operations | ||||||
Net Investment Income1 | .444 | .856 | .801 | .734 | .617 | .594 |
Net Realized and Unrealized Gain (Loss) on Investments | 4.704 | 4.416 | (1.743) | 6.920 | 3.179 | 5.757 |
Total from Investment Operations | 5.148 | 5.272 | (.942) | 7.654 | 3.796 | 6.351 |
Distributions | ||||||
Dividends from Net Investment Income | (.448) | (.862) | (.798) | (.714) | (.616) | (.571) |
Distributions from Realized Capital Gains | — | — | — | — | — | — |
Total Distributions | (.448) | (.862) | (.798) | (.714) | (.616) | (.571) |
Net Asset Value, End of Period | $51.52 | $46.82 | $42.41 | $44.15 | $37.21 | $34.03 |
Total Return2 | 11.04% | 12.64% | -2.02% | 20.67% | 11.44% | 22.65% |
Ratios/Supplemental Data | ||||||
Net Assets, End of Period (Millions) | $15,293 | $13,962 | $12,471 | $12,903 | $10,685 | $9,955 |
Ratio of Total Expenses to Average Net Assets | 0.08%3 | 0.08%3 | 0.08%3 | 0.08% | 0.08% | 0.08% |
Ratio of Net Investment Income to Average Net Assets | 1.76% | 1.97% | 1.94% | 1.72% | 1.82% | 1.87% |
Portfolio Turnover Rate4 | 10% | 13% | 12% | 26% | 25% | 14% |
The expense ratio and net investment income ratio for the current period have been annualized. |
1 | Calculated based on average shares outstanding. |
2 | Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees. |
3 | The ratio of expenses to average net assets for the period net of reduction from custody fee offset arrangements was 0.08%. |
4 | Excludes the value of portfolio securities received or delivered as a result of in-kind purchases or redemptions of the fund’s capital shares, including ETF Creation Units. |
A. | The following significant accounting policies conform to generally accepted accounting principles for U.S. investment companies. The fund consistently follows such policies in preparing its financial statements. |
B. | In accordance with the terms of a Funds' Service Agreement (the “FSA”) between Vanguard and the fund, Vanguard furnishes to the fund investment advisory, corporate management, administrative, marketing, and distribution services at Vanguard’s cost of operations (as defined by the FSA). These costs of operations are allocated to the fund based on methods and guidelines approved by the board of trustees and are generally settled twice a month. |
C. | The fund’s custodian bank has agreed to reduce its fees when the fund maintains cash on deposit in the non-interest-bearing custody account. For the six months ended July 31, 2024, custodian fee offset arrangements reduced the fund’s expenses by $19,000 (an annual rate of less than 0.01% of average net assets). |
D. | Various inputs may be used to determine the value of the fund’s investments and derivatives. These inputs are summarized in three broad levels for financial statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in those securities. |
Level 1 ($000) | Level 2 ($000) | Level 3 ($000) | Total ($000) | |
Investments | ||||
Assets | ||||
Common Stocks | 97,023,354 | — | — | 97,023,354 |
Temporary Cash Investments | 247,608 | — | — | 247,608 |
Total | 97,270,962 | — | — | 97,270,962 |
Derivative Financial Instruments | ||||
Assets | ||||
Swap Contracts | — | 2,249 | — | 2,249 |
Liabilities | ||||
Futures Contracts1 | 62 | — | — | 62 |
Swap Contracts | — | 526 | — | 526 |
Total | 62 | 526 | — | 588 |
1 | Includes cumulative appreciation (depreciation) on futures contracts and centrally cleared swaps, if any, as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statement of Assets and Liabilities. |
E. | As of July 31, 2024, gross unrealized appreciation and depreciation for investments and derivatives based on cost for U.S. federal income tax purposes were as follows: |
Amount ($000) | |
Tax Cost | 65,034,456 |
Gross Unrealized Appreciation | 32,927,375 |
Gross Unrealized Depreciation | (690,931) |
Net Unrealized Appreciation (Depreciation) | 32,236,444 |
F. | During the six months ended July 31, 2024, the fund purchased $9,680,516,000 of investment securities and sold $9,388,206,000 of investment securities, other than temporary cash investments. In addition, the fund purchased and sold investment securities of $4,717,282,000 and $4,431,054,000, respectively, in connection with in-kind purchases and redemptions of the fund's capital shares. |
G. | Capital share transactions for each class of shares were: |
Six Months Ended July 31, 2024 | Year Ended January 31, 2024 | ||||
Amount ($000) | Shares (000) | Amount ($000) | Shares (000) | ||
ETF Shares | |||||
Issued | 5,029,685 | 27,959 | 7,008,963 | 44,964 | |
Issued in Lieu of Cash Distributions | — | — | — | — | |
Redeemed | (4,431,977) | (24,600) | (6,129,332) | (38,875) | |
Net Increase (Decrease)—ETF Shares | 597,708 | 3,359 | 879,631 | 6,089 | |
Admiral Shares | |||||
Issued | 942,816 | 19,273 | 1,767,035 | 40,614 | |
Issued in Lieu of Cash Distributions | 112,931 | 2,288 | 216,949 | 5,065 | |
Redeemed | (1,123,052) | (22,917) | (1,804,561) | (41,568) | |
Net Increase (Decrease)—Admiral Shares | (67,305) | (1,356) | 179,423 | 4,111 |
H. | Significant market disruptions, such as those caused by pandemics, natural or environmental disasters, war, acts of terrorism, or other events, can adversely affect local and global markets and normal market operations. Any such disruptions could have an adverse impact on the value of the fund’s investments and fund performance. |
I. | Management has determined that no events or transactions occurred subsequent to July 31, 2024, that would require recognition or disclosure in these financial statements. |
Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies.
Not applicable.
Item 9: Proxy Disclosures for Open-End Management Investment Companies.
Not applicable.
Item 10: Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.
Not applicable.
Item 11: Statement Regarding Basis for Approval of Investment Advisory Contracts.
Trustees Approve Advisory Arrangement – Energy Fund
The board of trustees of Vanguard Energy Fund has renewed the fund’s investment advisory arrangement with Wellington Management Company LLP (Wellington Management). The board determined that renewing the fund’s advisory arrangement was in the best interests of the fund and its shareholders.
The board based its decision upon an evaluation of the advisor’s investment staff, portfolio management process, and performance. This evaluation included information provided to the board by Vanguard’s Portfolio Review Department, which is responsible for fund and advisor oversight and product management. The Portfolio Review Department met regularly with the advisors and made presentations to the board during the fiscal year that directed the board’s focus to relevant information and topics.
The board, or an investment committee made up of board members, also received information throughout the year during advisor presentations conducted by the Portfolio Review Department. For the advisor presentation, the board was provided with letters and reports that included information about, among other things, the advisory firm and the advisor’s assessment of the investment environment, portfolio performance, and portfolio characteristics.
In addition, the board received periodic reports throughout the year, which included information about the fund’s performance relative to its peers and benchmark, as applicable, and updates, as needed, on the Portfolio Review Department’s ongoing assessment of the advisor.
Prior to their meeting, the trustees were provided with a memo and materials that summarized the information they received over the course of the year. They also considered the factors discussed below, among others. However, no single factor determined whether the board approved the arrangements. Rather, it was the totality of the circumstances that drove the board’s decision.
Nature, extent, and quality of services
The board reviewed the quality of the fund’s investment management services over both the short and long term and took into account the organizational depth and stability of the advisor. The board considered that Wellington Management, founded in 1928, is among the nation’s oldest and most respected institutional investment managers. The investment team uses a bottom-up approach in which stocks are selected based on the advisor’s estimates of fundamental investment value. Fundamental research focuses on the quality of a company’s assets, the company’s internal reinvestment opportunities, and management quality. The firm has advised the fund since its inception in 1984.
The board concluded that the advisor’s experience, stability, depth, and performance, among other factors, warranted the continuation of the advisory arrangement.
Investment performance
The board considered the short- and long-term performance of the fund, including any periods of outperformance or underperformance compared with a relevant benchmark index and peer group. The board concluded that the performance was such that the advisory arrangement should continue.
Cost
The board concluded that the fund’s expense ratio was below the average expense ratio charged by funds in its peer group and that the fund’s advisory expense rate was also below the peer-group average.
The board did not consider the profitability of Wellington Management in determining whether to approve the advisory fee because Wellington Management is independent of Vanguard and the advisory fee is the result of arm’s-length negotiations.
The benefit of economies of scale
The board concluded that the fund’s shareholders benefit from economies of scale because of breakpoints in the fund’s advisory fee schedule for Wellington Management. The breakpoints reduce the effective rate of the fee as the fund’s assets managed by Wellington Management increase.
The board will consider whether to renew the advisory arrangement again after a one-year period.
Trustees Approve Advisory Arrangement – Health Care Fund
The board of trustees of Vanguard Health Care Fund has renewed the fund’s investment advisory arrangement with Wellington Management Company LLP (Wellington Management). The board determined that renewing the fund’s advisory arrangement was in the best interests of the fund and its shareholders.
The board based its decision upon an evaluation of the advisor’s investment staff, portfolio management process, and performance. This evaluation included information provided to the board by Vanguard’s Portfolio Review Department, which is responsible for fund and advisor oversight and product management. The Portfolio Review Department met regularly with the advisor and made presentations to the board during the fiscal year that directed the board’s focus to relevant information and topics.
The board, or an investment committee made up of board members, also received information throughout the year during advisor presentations conducted by the Portfolio Review Department. For each advisor presentation, the board was provided with letters and reports that included information about, among other things, the advisory firm and the advisor’s assessment of the investment environment, portfolio performance, and portfolio characteristics.
In addition, the board received periodic reports throughout the year, which included information about the fund’s performance relative to its peers and benchmark, as applicable, and updates, as needed, on the Portfolio Review Department’s ongoing assessment of the advisor.
Prior to their meeting, the trustees were provided with a memo and materials that summarized the information they received over the course of the year. They also considered the factors discussed below, among others. However, no single factor determined whether the board approved the arrangement. Rather, it was the totality of the circumstances that drove the board’s decision.
Nature, extent, and quality of services
The board reviewed the quality of the fund’s investment management services over both the short and long term and took into account the organizational depth and stability of the advisor. The board considered that Wellington Management, founded in 1928, is among the nation’s oldest and most respected institutional investment managers. The portfolio manager is aided by a team of experienced Global Industry Analysts who cover health care industries. This health care team uses intensive fundamental analysis and deep knowledge of health care science and technology to identify companies with high-quality balance sheets, strong management, and the potential for new products that will lead to above-average growth in revenue and earnings. The advisor invests in stocks broadly representing the health care industry, seeking to maintain exposure across five primary subsectors: large-cap biotech/pharmaceuticals, mid-cap biotech/pharmaceuticals, small-cap biotech/pharmaceuticals, health care services, and medical technology. Wellington Management has advised the fund since its inception in 1984.
The board concluded that the advisor’s experience, stability, depth, and performance, among other factors, warranted continuation of the advisory arrangement.
Investment performance
The board considered the short- and long-term performance of the fund, including any periods of outperformance or underperformance compared with a relevant benchmark index and peer group. The board concluded that the performance was such that the advisory arrangement should continue.
Cost
The board concluded that the fund’s expense ratio was below the average expense ratio charged by funds in its peer group and that the fund’s advisory fee rate was also below the peer-group average.
The board did not consider the profitability of Wellington Management in determining whether to approve the advisory fee because Wellington Management is independent of Vanguard and the advisory fee is the result of arm’s-length negotiations.
The benefit of economies of scale
The board concluded that the fund’s shareholders benefit from economies of scale because of breakpoints in the fund’s advisory fee schedule for Wellington Management. The breakpoints reduce the effective rate of the fee as the fund’s assets increase.
The board will consider whether to renew the advisory arrangement again after a one-year period.
Trustees Approve Advisory Arrangement – Dividend Appreciation Index Fund
The board of trustees of Vanguard Dividend Appreciation Index Fund has renewed the fund’s investment advisory arrangement with The Vanguard Group, Inc. (Vanguard), through its Equity Index Group. The board determined that continuing the fund’s internalized management structure was in the best interests of the fund and its shareholders.
The board based its decision upon an evaluation of the advisor’s investment staff, portfolio management process, and performance. This evaluation included information provided to the board by Vanguard’s Portfolio Review Department, which is responsible for fund and advisor oversight and product management. The Portfolio Review Department met regularly with the advisor and made presentations to the board during the fiscal year that directed the board’s focus to relevant information and topics.
The board, or an investment committee made up of board members, also received information throughout the year during advisor presentations conducted by the Portfolio Review Department. For each advisor presentation, the board was provided with letters and reports that included information about, among other things, the advisory firm and the advisor’s assessment of the investment environment, portfolio performance, and portfolio characteristics.
In addition, the board received periodic reports throughout the year, which included information about the fund’s performance relative to its peers and benchmark, as applicable, and updates, as needed, on the Portfolio Review Department’s ongoing assessment of the advisor.
Prior to their meeting, the trustees were provided with a memo and materials that summarized the information they received over the course of the year. They also considered the factors discussed below, among others. However, no single factor determined whether the board approved the arrangement. Rather, it was the totality of the circumstances that drove the board’s decision.
Nature, extent, and quality of services
The board reviewed the quality of the fund’s investment management services over both the short and long term and took into account the organizational depth and stability of the advisor. The board considered that Vanguard has been managing investments for more than four decades. The Equity Index Group adheres to a sound, disciplined investment management process; the team has considerable experience, stability, and depth.
The board concluded that Vanguard’s experience, stability, depth, and performance, among other factors, warranted continuation of the advisory arrangement.
Investment performance
The board considered the short- and long-term performance of the fund, including any periods of outperformance or underperformance compared with its target index and peer group. The board concluded that the performance was such that the advisory arrangement should continue.
Cost
The board concluded that the fund’s expense ratio was below the average expense ratio charged by funds in its peer group and that the fund’s advisory expenses were also below the peer-group average.
The board does not conduct a profitability analysis of Vanguard because of Vanguard’s unique structure. Unlike most other mutual fund management companies, Vanguard is owned by the funds it oversees.
The benefit of economies of scale
The board concluded that the fund’s arrangement with Vanguard ensures that the fund will realize economies of scale as it grows, with the cost to shareholders declining as fund assets increase.
The board will consider whether to renew the advisory arrangement again after a one-year period.
Item 12: Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 13: Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 14: Purchase of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 15: Submission of Matters to a Vote of Security Holders.
Not applicable.
Item 16: Controls and Procedures.
(a) Disclosure Controls and Procedures. The Principal Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on their evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.
(b) Internal Control Over Financial Reporting. In February 2024, a third-party service provider began performing security pricing services for the Registrant. There were no other changes in the Registrant’s Internal Control Over Financial Reporting or in other factors that could significantly affect this control during the period covered by this report, including any corrective actions with regard to significant deficiencies and material weaknesses.
Item 17: Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 18: Recovery of Erroneously Awarded Compensation.
Not applicable.
Item 19: Exhibits.
(a)(1) | Not applicable. |
(a)(2) | Certifications filed herewith. |
(a)(2) | Certifications filed herewith. |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
VANGUARD SPECIALIZED FUNDS | ||
BY: | /s/ SALIM RAMJI* | |
SALIM RAMJI | ||
CHIEF EXECUTIVE OFFICER |
Date: September 20, 2024
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
VANGUARD SPECIALIZED FUNDS | ||
BY: | /s/ SALIM RAMJI* | |
SALIM RAMJI | ||
CHIEF EXECUTIVE OFFICER |
Date: September 20, 2024
VANGUARD SPECIALIZED FUNDS | ||
BY: | /s/ CHRISTINE BUCHANAN* | |
CHRISTINE BUCHANAN | ||
CHIEF FINANCIAL OFFICER |
Date: September 20, 2024
* By: | /s/ John E. Schadl |
John E. Schadl, pursuant to a Power of Attorney filed on July 25, 2024 (see File Number 33-48863), Incorporated by Reference.